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CURRENT ISSUES
ACQUIRED IMMUNODEFICIENCY
SYNDROME: THE CASE FOR
ANONYMOUS LIMITED DISCOVERY
First recognized by the Centers for Disease Control ("CDC") in
June 1981,' Acquired Immunodeficiency Syndrome ("AIDS") is
' I. SLOAN, AIDS LAW: IMPLICATIONS FOR THE INDIVIDUAL & SOCIETY 1,1 (1988). According
to Dr. James W. Curran, Director of HIV/AIDS of the Centers for Disease Control, the
earliest known documented case of AIDS was later found to have occurred in 1959, in
Zaire. J. Curran, Remarks at New Advances in AIDS: A Forum for Health Care Planners
and Providers (October 17, 1990) (Albert Einstein College of Medicine, New York) [here-
inafter "Forum"]. The CDC later recognized at least one American case of AIDS as early
as 1979, and tests for the presence of the antibody to the AIDS virus on stored serum were
found positive in a specimen from 1976. See Gibofsky & Laurence, AIDS-Current Medical
and Scientific Aspects, in 9 J.L. MED. 497, 497 (1988).
In terms of epidemiology, the incidence of AIDS cases in the United States is concen-
trated in certain geographical areas, particularly New York, New Jersey, Florida, Texas
and California. H. Jaffe, The Medical Facts About AIDS, in AIDS AND THE CouRTS 7, 12 (C.
Abt and K. Hardy eds. 1990). Currently, the highest concentration of cases is in the Dade
County, Miami, Florida area. Id. AIDS is the leading cause of death in New York for males
aged 25 to 44, and females aged 25 to 34. See S. Joseph, HIV Testing and te Criminal Justice
System in New York City, in AIDS AND THE Couxrs 53, 54 (C. Abt and K. Hardy eds. 1990).
As of February 1989, approximately 19,000 cases of AIDS and over 10,000 AIDS-related
deaths had been reported in New York City, and 60,000 AIDS cases and 48,000 AIDS-
related deaths are projected for the New York area by 1993. Id.
The majority of AIDS cases have been diagnosed in men, with only nine percent of the
total reported cases affecting women. See Jaffe, supra, at 12. Further, the disease has
predominantly been found in the twenty to forty-five year old age category. Id. With re-
gard to ethnicity, blacks have accounted for twenty-five percent of adult and fifty-six per-
cent of pediatric cases; Hispanics account for thirteen percent of adult and twenty percent
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an infectious disease which attacks the body's immune system,
thereby significantly impairing its ability to fight invading bacteria
and other infectious agents.' While the growth rate of new AIDS
cases has decreased significantly,3 the number of infected persons
continues to rise in absolute terms.' The disease has raised many
social, political, and legal issues.8 One particular legal issue con-
of pediatric cases through 1987. AMERICAN BAR ASSOCIATION, AIDS: THE LEGAL ISSUES, DIs-
CUSSION DRAFT OF THE AMERICAN BAR ASSOCIATION AIDS COORDINATING COMMITTEE 9
(1988).
For further discussion of epidemiological issues raised, see generally Mueller, The Eide-
miology of the Human Immunodeficiency Virus Infection, 14 LAW, MED. & HEALTH CARE 250,
258 (1987); AIDS: Science and Epidemiology, 14 LAW, ME. & HEALTH CARE 225 (1986);
Weiss & Biggar, The Epidemiology of Human Retrovirus-Associated Illnesses, 53 MOUNT SINAI J.
OF MED. 579 (1986).
' See UNITED STATES DEP'T OF HEALTH AND HUMAN SERVICES, SURGEON GENERAL'S REPORT
ON ACQUIRED IMMUNO-DEFICIENCY SYNDROME 9 -10 (1986). The Human Immuno-deficiency
Virus ("HIV") causes AIDS by breaking down the body's immune system, making an in-
fected person unusually susceptible to various viral, protozoal, fungal, and bacterial infec-
tions which a healthy person's immune system could resist. Id. See AIDs AND THE LAW 264
(W. Dornette ed. 1987) (CDC definition of AIDS); 36 MoRBIDrrv & MORTALITY WEEKLY
REP. (Supp. IS, Aug. 14, 1987) (CDC's revised definition of AIDS).
' Gibofsky & Laurence, supra note 1, at 497 (citing J. LAURENCE, THE AIDS READER
(1987)).
' See H. Jaffe, The Medical Facts About Aids, in AIDS AND THE COURTS 7, 12 (C. Abt and K.
Hardy eds. 1990) (83,000 domestic cases at beginning of 1989); New York State Dep't of
Health, AIDS: 100 Questions and Answers (April 1989) (pamphlet distributed by AIDS Advi-
sory Council) (90,000 cases as of March 1989). As of September 1990, 152,126 domestic
cases of AIDS have been reported to the CDC, a portentous increase in the last year alone.
Telephone interview with member of Technical Information Activity Staff of CDC (Nov.
1, 1990).
The CDC has estimated that by the end of 1992 there will be more than a third of a
million AIDS cases in this country, with more than a quarter of a million deaths. Jaffe,
supra, at 14. For 1992 alone it has been estimated that "80,000 new cases would be re-
ported, and 66,000 Americans would die of AIDS." Id. Furthermore, the CDC has esti-
mated that an additional 1.5 million Americans have been infected with HIV, and twenty
to fifty percent of those infected are expected to ultimately develop AIDS. See INSTITUTE OF
MEDICINE, NATIONAL ACADEMY OF SCIENCES, CONFRONTING AIDS: DIRECTIONS FOR PUBLIC
HEALTH, HEALTH CARE AND RESEARCH 5 (1986).
If these projections prove correct, by 1992 AIDS will be the second leading cause of
premature death in the United States, and will nearly equal unintentional injury-largely
automobile accidents-as the leading cause of premature death in men. Jaffe, supra, at 15.
' See, e.g., Thompson, A Losing Battle with AIDS, TIME, July 2, 1990, at 42-43 (medical
developments and Sixth International Conference on AIDS in San Francisco); Gostin, The
AIDS Litigation Project. A National Review of Court and Human Rights Commission Decisions,
Part I: The Social Impact of AIDS, 263 J. A.M.A. 1961-70 (1990) (consequences of AIDS in
society); Spece, AIDS: Due Process, Equal Protection, and the Right to Treatment, 4 IsSUES L.
MED. 283-344 (1988) (AIDS patients' right to medical treatment); Albert, A Right to Treat-
mentfor AIDS Patients?, 92 DICE. L. REV 743 (1988) (same); Levhers, et al., AIDS and Medi-
caid: The Role of Medicaid in Treating those with AIDS, 44 PuBLIc WELFARE 20 (government
programs to finance care of AIDS patients).
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cerns the liability of blood banks and hospitals for, respectively,
supplying and transfusing individuals with AIDS-infected blood.
Despite the development of screening tests for AIDS 7 a signifi-
cant risk of infection by transfusion of blood remains,* given the
nature of the disease9 and the fact that current screening tests
For a discussion of the consequences of AIDS in the work-force, see generally Shut-
tleworth v. Broward County Office of Budget and Management Policy, 639 F. Supp. 654 (S.D. Fla.
1986) (rights of employee fired for having AIDS); Gostin, The AIDS Litigation Project. A
National Review of Court and Human Rights Commission Decisions, Part I1: Discrimination, 263
J. A.MA. 2086-93 (1990) (discrimination against persons with AIDS); Brown, AIDS in the
Workplace; A Legal Dilemma, 43 Sw. L.J. 837 (1988) (AIDS-related problems of discrimina-
tion and privacy in workplace, including employee and applicant testing); M. Cecire, AIDS
Presents Many Legal Issuesfor Workplace, Legal Times, Dec. 2, 1985, at 13-14 (same).
For examples of AIDS and education concerns, see generally Thomas v. Atascadero Unified
School Dist., 622 F. Supp. 376 (C.D. Cal. 1987) (child with AIDS entitled to protection from
discrimination in school); Jones, The Education for All Handicapped Children Act: Coverage of
Children with Acquired Immune Deficiency Syndrome (AIDS), 15 J.L. & EDUC. 195 (1986) (social
issues involved in education of children with AIDS); Sotto, Undoing a Lesson of Fear in the
Classroom: The Legal Recourse of AIDS-Linked Children, 135 U. PA. L. REv 193 (1986) (same).
I See Rabkin, Individual and Institutional Liability for Transfusion-Acquired Diseases, 256 J.
A.M.A 2242-43 (1986) (unless and until legislatures or judiciary revoke classification of
blood as service, liability can only be grounded in negligence); Miller, Potential Liability for
Transfusion-Associated AIDS, 253 J. A.M.A. 3419-23 (1985) (discussing hospital, blood bank,
and physician liability) Hermann, Liability Related to Diagnosis and Transmission of Aids, 15
LAw, MED. & HEALTH CARE 36-45 (Summer 1987) (liability related to medical malpractice
and transfusions via blood, needle sharing, childbirth, and sexual intercourse). See also
notes 16 through 58 and accompanying text (discussing blood bank and hospital liability).
I See Ward, Grindon, Feorino et al., Laboratory and Epidemiologic Evaluation of an Enzyme
Immunoassay for Antibodies to HTLV-Ill, 256 J. A.M.A. 357, 361 (1986); Weiss, Goedert,
Sarngadharan et al., Screening Test for HTLV-Il! (AIDS-agent) Antibodies: Specificity, Sensitivity,
and Applications, 253 J. A.M.A. 221, 225 (1985).
1 See Cohen, Munoz, Reitz, et al., Transmission of Retrovirus by Transfusion of Screened
Blood in Patients Undergoing Cardiac Surgery, 320 NEW ENG. J. MED. 1172-76 (1989) (1 in
36,282); Kleinman & Secord, Risk of Human Immunodeficiency Virus (HIV) Transmission by
Anti-HIV Negative Blood: Estimates Using the Lookback Methodology, 28 TRANSFUSION 499-501
(1988) (1 in 68,000); Peterman, Lui, Lawrence, Allen, Estimating the Risks of Transfusion-
Associated Acquired Immunodeficiency Syndrome and Human Immunodeficiency Virus Infection, 27
TRANSFUSION 371-74 (1987) (predicting 29,000 infections transmitted between 1978 and
1984).
The CDC has estimated that the overall risk of becoming infected with HIV following a
transfusion is currently 1 in 40,000. Jaffe, supra note 4, at 24.
* See Forum, supra note 1 (statement of Dr. Ruy Soeiro). According to Dr. Soeiro, there
is an initial latent phase of the disease, during which there is an apparent immunity to
HIV. Accord Gibofsky & Laurence, AIDS--Current Medical and Scientific Aspects, in 9 J.L
MEw. 497, 499 (1988) ("Antibodies to HIV-1 . . . occur earliest in the course of viral infec-
tion; however, the levels of antibodies may fall and become undetectable .... "). In Dr.
Soeiro's opinion, it is the acute stage, featuring a loss of CD-4 cells - a sub-population of
T-cell lymphocytes (white blood cells) - which are vital to the immune system, that is the
best marker of the condition of the patient. See Forum, supra note 1.
The latent characteristic of the disease is particularly consequential in the transfusion
setting, given the uncertainty of the interval for "seroconversion" (testing positive for
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provide ambiguous results.10 One study projected that there
would be at least 10,600 transfusion-related AIDS cases stemming
from pre-1985 infection."1 Moreover, several researchers point
out that the attainment of a blood supply with a zero-risk of trans-
mitting infectious disease may not be possible. 2
To further complicate the ordeal of the person transfused with
AIDS-infected blood, courts have denied the aggrieved victims
HIV-antibody) following infection. Gibofsky & Laurence, supra, at 499-500. That is, stud-
ies have indicated that seroconversion may not occur in some individuals for nine to twelve
months. Id. As potential donors, these asymptomatic individuals-while seronegative for
the antibody-may be harboring the active virus in infected cells, and represent an obvious
dilemma for blood transfusion facilities and blood suppliers. Id.
1* AIDS LEGAL GUIDE 4-3, 4-4 (A. Rubenfeld ed. 1987) (current HIV-antibody tests are
apt to provide false positive results); Osborn, HIV Antibody Testing Uses and Limitations, in
AIDS AND THE Cour's 45 (C. Abt. and K. Hardy eds. 1987) ("ELISA test ... is prone to
errors of timing, technical mishap, or biologic ambiguity"); Howard, HIV Screening - Sci-
entific, and Legal Issues, 9 JL. MED. 601, 603-04 (1988) ("positive predictive value can vary
greatly depending on ... prevalence of HIV infection in a particular group screened");
Ward et al., Transmission of Human Immunodeficiency Virus (HI) by Blood Transfusions As
Negative for HIV Antibody, 318 NEw ENG. J. MED. 473, 473 (1988) (present tests may not
identify antibody) (footnotes omitted); Barnes, AIDS Test is, Unfortunately, Still Ambiguous,
N.Y. Times, May 5, 1987, at A34, col.3 (ambiguous characteristics of AIDS test results).
Several studies estimate that four to five of every I million donors screened as negative for
HIV may be infected. Ward, supra, at 476 (citing Bove, Transfusion-Associated Hepatitis and
AIDS: What is the Risk?, 317 NEw ENG. J. ME. 242-45 (1987) (emphasis added)). Conse-
quently, according to these figures, seventy-two to ninety persons may be infected each
year under these circumstances. Ward, supra, at 476. More importantly, if the likelihood of
donation before the development of detectable antibody is taken into account, i.e, during
the latent stage, it has been predicted that as many as 460 recipients of screened blood may
become infected annually. Id. Cf. Peterman & Ward, What's Happening to the Epidemic of
Transfusion-Associated AIDS?, 29 TRANSFUSION 659, 659 (1989) (793 cases of transfusion-
associated AIDS reported from July 1988 to June 1989).
Recommending that the Food and Drug Administration should make new antigen tests
available to blood banks immediately, Dr. Allan Salzburg, a physician at the Veteran's Ad-
ministration Medical Center, pointed out that despite the use of the ELISA (enzyme-linked
immunosorbent assay) test, HIV cannot be detected in about seven percent of the carriers
tested. A. Salzburg, Letter to the Editor, 319 NEW ENG. J. MED. 515, 515 (1988). Further, the
author stated that in areas such as New York and San Francisco, where the presence of
HIV is ten to fifteen times above the national average, "two to four units per 19,000 could
be contaminated and go undetected." Id.
,1 Kalbfleisch & Lawless, Estimating the Incubation Time Distribution and Expected Number of
Cases of Transfusion-Associated Acquired Immune Deficiency Syndrome, 29 TRANSFUSION 672,
674-75 (1989). The authors note that "these numbers of observed recent infections would
suggest a large number of future cases and therefore a substantial infection rate after
1985." Id. at 675. Moreover, if long-term projections are adjusted for the change in the
surveillance definition of AIDS in 1987 - 22 percent of all transfusion-related AIDS cases
reported in 1988 were diagnosed by the new classification - these estimates would be
conspicuously higher. Peterman & Ward, supra note 10, at 660.
11 Peterman & Ward, supra note 10, at 659-60 (citing Greetings, A Final Look Back With
Comments About A Policy of Zero-Risk Blood Supply, 27 TRANSFUSiON 447, 447-48 (1987)).
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discovery of information regarding donor identity's on constitu-
tional and policy grounds."4 Since donor identity is essential in es-
tablishing blood bank or hospital liability, this denial is often det-
rimental to the victim's case.'0 This Note will examine the issue of
anonymous limited discovery in AIDS cases, in light of the diver-
gence of trial court opinions in this area. Part One of this Note
will discuss a plaintiff's possible causes of action, and the need for
discovery of the donor's identity. Part Two will review the Fed-
eral Rules of Civil Procedure regarding discovery, defining the
scope and limitations of its application. Part Three will address
the donor's informational right to privacy. Part Four will discuss
the public policy issues raised, particularly the potential impact on
voluntary blood supplies. Part Five will examine the balancing test
used to weigh the parties' respective interests, in light of recent
case law. Finally, Part Six will propose the application of anony-
mous limited discovery by courts as one practical approach to such
cases.
I. THEORIES OF RECOVERY
An individual who has contracted AIDS via a transfusion of
contaminated blood will often seek to recover damages from a
hospital," blood bank,17 or blood product manufacturer,' de-
" See infra notes 133-148 and accompanying text (cases denying discovery).
14 Id.
"See infra notes 35-58 and accompanying text (reviewing causes of action).
"See, e.g., Cutler v. Graduate Hosp., 717 F. Supp. 338 (E.D. Pa. 1989) (patient brought
personal injury action against hospital for transfusing AIDS-infected blood during opera-
tion); Mason v. Regional Medical Center of Hopkins County, 121 F.R.D. 300 (W.D. Ky.
1988) (patient who received AIDS-infected transfusions during child birth brought suit
against hospital for supplying unreasonably dangerous product); Robert v. Suburban Hop.
Ass'n, 73 Md. App. 1, 532 A.2d 1081 (Md. Ct. Spec. App. 1987) (hemophiliac brought suit
against hospital seeking damages resulting from contraction of AIDS through transfusion
of contaminated blood); Stenger v. Lehigh Valley Hosp. Center, 386 Pa. Super. 574, 563
A.2d 531 (1989) (patient brought negligence action against hospital in connection with
transfused blood from donor who tested positive for AIDS virus); Longoria v. McAllen
Methodist Hop., 771 S.W.2d 663 (Tex. Ct. App. 1989) (parents of four year-old child who
died of AIDS brought tort action against hospital which supplied blood). For further dis-
cussion of hospital liability in transfusion-related AIDS cases, see Comment. Hospital and
Blood Bank Liability to Patients Who Contract AIDS Through Blood Transfumions, 23 SAN DIEGO
L. REv. 875 (1986) (negligence is only viable theory of recovery against hospital for AIDS-
infected transfusion) [hereinafter "Comment, Hospital and Blood Bank Liability"].
Although a plaintiff in a transfusion-related AIDS case will almost certainly sue the hos-
pital which administered the transfusion, plaintiffs will generally name a blood bank as a
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pending on the circumstances of the underlying transfusion proce-
dure. In such cases, a plaintiff will usually pursue a remedy based
co-defendant if the hospital has purchased the contaminated blood from that independent
supplier. See, e.g., Cutler, 717 F. Supp. at 338 (American National Red Cross named co-
defendant); Kozup v. Georgetown Univ., 663 F. Supp. 1048 (D.D.C. 1987). modified, 851
F.2d 437 (D.C. Cir. 1988) (American Red Cross named co-defendant); Longoria, 771
S.W.2d at 663 (United Blood Services named co-defendant).
" See, e.g., Bradway v. American Nat'l Red Cross, 132 F.R.D. 78 (N.D.Ga. 1990) (recipi-
ent of AIDS-contaminated blood brought action against blood supplier); Hoemke v. New
York Blood Center, No. 88 Civ. 9029 (S.D.N.Y. Nov. 28, 1989) (1989 WESTLAW 14767,
AlIfed library) (patient who contracted AIDS from 1981 blood transfusion brought suit
against blood center), affd, 912 F.2d 550 (2d Cir. 1990); Boutte v. Blood Sys., Inc., 127
F.R.D. 122 (W.D. La. 1989) (donee who received blood transfusion brought action against
blood bank after testing positive for HIV antibody); Doe v. American Red Cross Blood
Serv., 125 F.R.D. 646 (D.S.C. 1989) (plaintiff who contracted AIDS virus as result of blood
transfusion brought action against blood bank); Howell v. Spokane & Inland Empire Blood
Bank, 114 Wash. 2d 42, 785 P.2d 815 (1990) (en banc) (AIDS victim filed strict liability
and implied warranty action against blood bank that supplied hospital with infected blood).
For further discussion of blood bank liability, see generally Comment, Hospital and Blood
Bank Liability, supra note 16; Comment, Transfusion-Associated Acquired Immunodeficiency
Syndrome (AIDS): Blood Bank Liability?, 16 U. BALT. L. REv. 81 (1986) (under present law,
victims of transfusion-associated AIDS will find it almost impossible to recover against
blood banks) [hereinafter "Comment, Transfusion-Associated AIDS"].
" See, e.g., Miles Laboratories, Inc., Cutter Laboratories Div. v. Doe, 315 Md. 2d 704,
708, 556 A.2d 1107, 1109 (1989). A blood product manufacturer is, inter alia, a commer-
cial preparer and supplier of a blood clotting factor concentrate. Id. See McKee v. Miles
Laboratories, Inc., 675 F. Supp. 1060, 1061 (E.D. Ky. 1987). Since hemophiliacs lack the
protein Factor VIII necessary for normal coagulation of blood, these companies have de-
veloped a method by which this absent protein can be produced and distributed to
hemophiliacs. Id. First, blood plasma is purchased from blood donors. Id. All the purchased
plasma is then combined (or pooled) with plasma donated from thousands of other individ-
uals. Id. The Factor VIII is then precipitated out of those combined plasma and is freezed
dried and packaged in powdered form. See Rodgers v. Miles Laboratories, Inc., 802 P.2d
1346, 1347, (Wash. 1991) (en banc). Finally, this blood clotting factor concentrate is sold
to hospitals and physicians where it is administered intravenously by mixing the powdered
concentrate with sterile water prior to use. Id. See generally 21 C.F.R. § 640 (1990) (regula-
tions governing human blood and blood products).
Since the medical community has determined that the HIV virus can be transmitted
through blood plasma, hemophiliacs who have developed AIDS from using this factor con-
centrate have begun to sue the manufacturers of this product. See, e.g., Coffee v. Cutter
Biological, 809 F.2d 191 (2d Cir. 1987) (plaintiffs brought product liability suit against
commercial producers of blood component products); Ray v. Cutter Laboratories, 744 F.
Supp. 1124 (M.D. Fla. 1990) (mother of three hemophiliac children infected with AIDS
virus brought suit against various plasma product manufactures); Doe v. Travenol Labora-
tories, 698 F. Supp. 780 (D. Minn. 1988) (patient infected with AIDS virus while using
anti-hemophiliac factor filed suit against product's manufacturer); McKee v. Miles Labora-
tories, Inc., 675 F. Supp. 1060 (E.D. Ky. 1987) (widow of hemophiliac brought suit against
supplier of blood coagulant); Miles Laboratories, Inc., Cutter Laboratories Div. v. Doe, 315
Md. 704, 556 A.2d 1107 (1989) (action brought against supplier of blood products on
behalf of hospital patients who contracted AIDS virus); Rodgers v. Miles Laboratories,
Inc., 116 Wash. 2d 195, 802 P.2d 1346 (1991) (guardian of child infected with AIDS filed
product liability action against manufacturer of blood products).
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on several legal theories:"9 strict liability,'0 implied warranty, 1
and negligence."
A. Strict Liability in Tort
In transfusion-related AIDS cases, a plaintiff may attempt to re-
cover damages under the theory of strict liability in tort, which
has its basis in the Restatement (Second) of Torts." Under this
to See, I. SLOAN, AIDS LAW: IMPLICATIONS FOR THE INDIVIDUAL & SOCIETY (1988) (tort
liability for transmission of AIDS through blood supply).
Although the most common theories to sue under are strict liability in tort, implied war-
ranty, and negligence, it should be recognized that many additional theories of recovery
exist under which a plaintiff may pursue compensation in a transfusion-associated setting.
See Hoemke v. New York Blood Center, No. 88 Civ. 9029 (S.D.N.Y. Nov. 28, 1989) (1989
WESTLAW 147642, AlIfed library) (fraud and breach of fiduciary duty), affd, 912 F.2d
550, 551 (2d Cir. 1990); Kozup v. Georgetown Univ., 663 F. Supp. 1048, 1051 (D.D.C.
1987) (battery and informed consent), modified, 851 F.2d 437 (D.C. Cir. 1988); Savino v.
Nassau Hosp., 127 App. Div. 2d 579, 580, 511 N.Y.S.2d 379, 380 (2d Dep't 1987) (wrong-
ful death); Howell v. Spokane & Inland Empire Blood Bank, 785 P.2d 815, 817 (Wash.
1990) (en banc) (violation of consumer protection act).
Although liability may be imposed upon a blood supplier, it would be virtually impossible
for a transfusion-related AIDS victim to recover damages from the donor of the contami-
nated blood. See Williams, Blood Transfsions and AIDS: A Legal Perspective, 32 MED. TRIAL
TzcH. Q. 267, 271 (1986) [hereinafter "Williams"]. In order to prove that the donor was
negligent, the transfusion-associated AIDS victim would have to demonstrate that the do-
nor knew or should have known that he was infected with or was a carrier of AIDS, and
that the disease could endanger a transfusion recipient. Id. Further, even assuming the
plaintiff could demonstrate that the donor was negligent in donating the blood, the trans-
fusion recipient would probably be unable to recover damages since the usual donor would
not have the insurance or the resources to satisfy the claim. Id. For a discussion of the
potential criminal ramifications of intentionally or negligently donating contaminated
blood, see I. SLOAN, supra, at 17-21.
o See infra notes 23-27 and accompanying text (discussing strict liability).
I See infra notes 28-34 and accompanying text (discussing implied warranty).
n See infra notes 35-58 and accompanying text (discussing negligence).
- RESTATEMENT (SECOND) OF TORTS §402(a) (1965). The Restatement provides:
(1) One who sells any product in a defective condition unreasonably dangerous to
the user or consumer or to his property is subject to liability for physical harm
caused to the ultimate user or consumer, or to his property, if
(a) the seller is engaged in the business of selling a product; and
(b) it is expected to and does reach the user or consumer without substantial change
in the condition in which it was sold;
(2) The rule stated in subsection (1) applies although
(a) the seller has exercised all possible care in the preparation and sale of his prod-
uct; and
(b) the user or consumer has not brought the product from or entered into any
contractual relationship with the seller.
Id. Section 402(a) has been adopted, in some form or another, by almost every state. See
W.P. KEETON, D. Doas, R. KErON & D. OWEN, PROSSER AND KEETON ON THE LAW OF TORTS
§ 98, at 694 (5th ed. Supp. 1988) [hereinafter "PRossER AND KEErON"]. As of 1988, the
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theory, liability will be imposed upon a manufacturer or retailer
when a dangerously defective product causes physical injury or
property damage, irrespective of whether a particular defendant
was negligent." Section 402(a) of the Restatement, however, ex-
pressly limits the application of this theory to cases involving the
sale of a product. 5 The primary obstacle to recovering under this
theory has been the implementation of state "blood shield stat-
utes," which characterize the transfusion of blood or blood prod-
ucts as a service rather than as a sale of a product." As a conse-
only jurisdictions which had failed to expressly adopt the theory of strict tort liability for
defective products were Delaware, Massachusetts, Michigan, North Carolina, Virginia, and
the District of Columbia. Id.
Moreover, it is commonly stated that there are three reasons for holding manufacturers
and dealers strictly liable for personal or property injury caused by defective products. Id.
at 692. First, innocent victims should not be forced to bear the costs of accidents. Id. at
693. Second, strict liability promotes accident prevention because manufacturers are in a
better position to ascertain and control the risks associated with their products. Id. Third,
manufacturers are in a better position than individuals to bear the costs because they can
distribute the losses by charging higher prices for the costs of products. Id.
" RESTATEMENT (SECOND) OF Toars § 402 (a) (1965).
w Id.
" See, e.g., ALA. CODE §7-2-314(4) (1984); ARnz REv. STAT. ANN. §36-1151 (1986); CAL.
HLTH & SAFETY CODE § 1606 (West 1979); Ky. Rrv. STAT. ANN. § 139.125 (Michie/Bobbs-
Merril 1982); ME REv. STAT. ANN. tit. 11, §2-108 (Supp. 1989); MiNN. STAT. ANN. §525.928
(West 1975); Miss. CODE ANN. §41-41-1 (Supp. 1990); N.Y. Pus HEALTH LAW §580(4) (Mc-
Kinney Supp. 1989); OR. REv. STAT §97.300 (1984); UTAH CODE ANN. §26-31-1 (1989). Sev-
eral states have enacted statutes which only preclude recovery under strict liability, See, e.g.,
IOWA CODE ANN. §142A.8 (West 1989); LA. REv. STAT. ANN. §9:2797 (West Supp. 1990).
Other state statutes specifically preclude recovery under implied warranties of fitness and
merchantability. See, e.g., ALAsKA STAT. §45.02.316(e) (1986); AiE. STAT. ANN. §20-9-802
(1987); CONN. GrN. STAT. ANN. §19a-280 (West 1986); DEL CODE ANN. tit. 6, §2-316(5)
(1975); IDAHO CODE §39-3702 (Supp. 1989); Mo. ANN. STAT. §431.069 (Vernon Supp.
1989); N.D. CEr. CODE §41-02-33 (3)(d) (1983); TENN. CODE ANN. §47-2-316(5) (1979).
Some statutes specifically preclude recovery under strict liability, implied warranty of fit-
ness, and implied warranty of merchantability. See, e.g., GA. CODE ANN. § 105-1105 (Harri-
son 1990); ILL ANN. STAT. ch. I 1 '/2, para. 5102 (Smith-Hurd 1988); IND. CODE § 16-8-7-
2(a) (Burns Supp. 1989); KAN. STAT. ANN. §65-3701 (1985); MD. HEALTH GEN. CODE ANN.
§18402 (1987); W. VA. CODE §16-23-1 (1985).
Although New Jersey and the District of Columbia do not have a blood shield statute,
these jurisdictions apply the same restrictions through common law. See, e.g., Kozup v. Ge-
orgetown Univ., 663 F. Supp. 1048 (D.D.C. 1987) (under District of Columbia common
law, blood transfusion is considered to be medical service), modified, 851 F.2d 437 (D.C.
Cir. 1988); Brody v. Overlook Hosp., 127 N.J. Super. 331, 317 A.2d 392 (N.J. Sup. Ct.
1974) (blood transfusion deemed to be a service), af'd, 66 N.J. 448, 332 A.2d 596 (1975).
Only the state of Vermont lacks a blood shield policy.
The progenitor of the sales/service dichotomy vis-a-vis blood transfusions was the case of
Perlmutter v. Beth David Hosp., 308 N.Y. 100, 123 N.E.2d 792 (1954). In Perlmutter, a
plaintiff sought to recover damages for breach of implied warranty from a hospital claim-
ing that she had contracted hepatitis through a transfusion of contaminated blood. Id. at
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quence of the sale/service characterization, the plaintiff will not
likely succeed in an action based solely on strict liability.27
103, 123 N.E.2d at 793. In rejecting the plaintiff's claim, the court held that liability could
not attach because a blood transfusion did not constitute a sale under the provisions of
New York's Sales Act. Id. at 108, 123 N.E.2d at 795. The court reasoned that a blood
transfusion was merely an "incidental and very secondary adjunct" feature of a service
provided by a hospital. Id. at 106, 123 N.E.2d at 795. To label a transfusion as a sale, the
court noted, would make the hospital liable "no matter how careful, no matter that the
disease producing potential in the blood could not possibly be discovered .... " Id.
Although the Perlmutter Rule led to the enactment of the modern blood shield statutes, a
number of courts, as well as commentators, have nevertheless, criticized the Perlmutter
sale/service dichotomy. See, e.g., Russell v. Community Blood Bank, Inc., 185 So.2d 749,
752 (Fla. Dist. Ct. App. 1966) (distortion for Perlmutter court to twist sale into shape of
service), rev'd on other grounds, 196 So.2d 115 (Fla. 1967); Cunningham v. MacNeal Memo-
rial Hosp., 47 Il1. 2d 443, 444, 266 N.E.2d 897, 901 (1970) (Perlmutter view was unrealis-
tic); Boland, Strict Liability in Tort for Transfusing Contaminated Blood, 23 ARK. L. REV. 236,
247 (1969) (Perlmutter court justified its policy decision by resorting to "kind of nonunder-
standing nonsense, in awkwardly averring that a sale is not a sale"); Williams, supra note
19, at 274-275 (Perlmutuer Rule deficient because transfer of blood is sale despite fact that it
occurred in course of what may be labelled service transaction); Comment, Liability Without
Fault and the AIDS Plague Compel a New Approach to Cases of Transfusion-Transmitted Disease,
61 U. CoLO. L. REv. 81, 112 (1990) ("Perlmutter's sale/service distinction ignores develop-
ment in the law which incorporated principles of no-fault liability and the traditional prin-
ciple of warranty from contract law to create a new kind of warranty.") [hereinafter "Com-
ment, Liability Without Fault"). The general criticism levied against the Perlmutter
conclusion is that the court rendered a pure policy decision disguised under the veil of a
sale/service distinction. See Comment, Transfusion-Associated AIDS, supra note 17, at 89.
More specifically, commentators have suggested that the Perlmutter court characterized a
transfusion as a service in order to provide a legal basis of protection for the blood industry
against claims premised on implied warranty or strict liability. Id. at 90.
", See supra notes 23-26 and accompanying text (discussing strict liability cause of action).
It should also be noted that courts have held that strict liability does not apply in transfu-
sion-related AIDS cases because blood and blood products fall within the "unavoidable
unsafe product" exception to strict liability which is delineated in RESTATEMENT (SECOND)
oF TORTS § 402(a) comment k. See, e.g., Rodgers v. Miles Laboratories, Inc., 802 P.2d
1346, 1353 (Wash. 1991) (en banc). Under § 402(a) comment k, strict product liability is
not applicable to those "products which in the present state of human knowledge, are quite
incapable of being made safe for their intended and ordinary use .... [Sluch a product,
properly prepared, and accompanied by proper directions and warning, is not defective,
nor is it unreasonably dangerous." Id. Consequently, in Rodgers, the court held that a plain-
tiff who contracted AIDS through the use of factor concentrate did not have a cause of
action based upon strict liability because the relative value to society of this product out-
weighed the possible risks involved to the user. Id. at 1351. Contra Comment, Liability With-
out Fault, supra note 26, at 112-114 (liability without fault should always be applied in
transfusion-related AIDS cases since it is "soundest and the most conscionable approach"
to this problem). Moreover, the court in Rodgers also noted that, pursuant to comment k,
although a manufacturer of an unavoidably unsafe product would not be liable under strict
liability, if the manufacturer failed to warn of a defect of which it either knew or should
have known about, it would be liable under the theory of negligence. See Rodgers, 802 P.2d
at 1353.
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B. Implied Warranty
Alternatively, a plaintiff may rely on the theory of implied war-
ranty. Under section 2-314 of the Uniform Commercial Code, a
seller of goods is liable for breach of implied warranty where the
goods sold are not of merchantable quality.' 8 Similarly, Section 2-
315 imposes liability for breach of implied warranty when the
goods sold are not fit for the particular purpose for which they
were bought." In an attempt to establish liability, a transfusion-
related AIDS victim may argue that a blood supplier is bound by
an implied warranty that the blood or blood product sold was fit
for transfusion."o Recovery under this theory, however, is limited
by several doctrines.8 One limitation is that the transaction must
involve a "sale" of goods.8 Since almost every jurisdiction now
characterizes a blood transfusion as a service and not a sale, 8 im-
plied warranty, like strict liability, has also been of limited utility
to a plaintiff."
U.C.C. § 2-314 (1989).
" U.C.C. § 2-315 (1989).
- See, e.g., Cutler v. Graduate Hosp., 717 F. Supp. 338 (E.D. Pa. 1989) (plaintiff argued
blood supplier liable on theory of implied warranty for providing unfit product); Roberts v.
Suburban Hosp. Ass'n, 73 Md. App. 1, 532 A.2d 1081 (Md. Ct. Spec. App. 1987) (same);
Howell v. Spokane & Inland Empire Blood Bank, 785 P.2d 815 Wash. (1990) (en banc)
(same).
M See, e.g., U.C.C. § 2-314, 2-315 (1989) (there must be sale to create implied warranty);
U.C.C. § 2-316 (1989) (implied warranty may be excluded or modified through use of dis-
claimers); U.C.C. § 2-607 (1989) (in order for buyer to preserve his remedies, buyer must
notify seller within reasonable time of discovery of breach or be barred from recovery).
- U.C.C. § 2-314 (1989). § 2-314 (1) states that "unless excluded or modified (Section 2-
316), a warranty that goods shall be merchantable is implied in a contract for their sale if
the seller is a merchant with respect to goods of that kind." Id. Similarly, U.C.C. § 2-315
presupposes that the transaction involves a sale of goods. § 2-315 states that:
Where the seller at the time of contracting has reason to know any particular pur-
pose for which the goods are required and that the buyer is relying on the seller's
skill or judgment to select or furnish suitable goods, there is unless excluded or mod-
ified . .. an implied warranty that the goods shall be fit for such purpose.
Id.
" See supra note 26 and accompanying text (discussing state "blood shield statutes"
which characterize transactions as service).
" See, e.g., Coffee v. Cutter Biological, 809 F.2d 191, 193 (2d Cir. 1987) (Connecticut's
blood shield statute precludes assertion of implied warranty against commercial producers
of blood products); Doe v. Travenol Laboratories, Inc., 698 F. Supp. 780, 783 (D. Minn.
1988) (Minnesota's blood shield statute protects processors of blood from being liable for
breach of implied warranty); Cutler v. Graduate Hosp., 717 F. Supp. 338, 339 (E.D. Penn.
1984) (Pennsylvania's blood shield statute requires dismissal of breach of implied warranty
claim); Miles Laboratories, Inc., Cutter Laboratories Div. v. Doe, 315 Md. 704, 710, 556
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C. Negligence
A plaintiff will commonly pursue compensation based on a neg-
ligence theory given that strict liability and implied warranty
claims will likely be dismissed. 6 To recover on this basis, plaintiff
must prove that the defendant owed him a duty of care, that the
defendant breached that duty, and that the breach was the proxi-
mate cause of the plaintiffs injury."
When an individual receives a blood transfusion, the duty owed
to the recipient by the hospital, blood bank, or blood product
manufacturer is determined by the standard of due care applica-
ble to the industry at the time of the transfusion. 7 With regard to
blood testing, "this standard is based upon the ability of the medi-
cal community to discover the disease, as well as the ability to de-
A.2d 1107, 1110 (1989) (Maryland's blood shield statute abrogates implied warranty claims
against blood product suppliers); Howell v. Spokane & Inland Empire Blood Bank, 785
P.2d 815, 818 (Wash. 1990) (en banc) (Washington's blood shield statute precludes recov-
ery on implied warranty claim).
" See Ray v. Cutter Laboratories, 744 F. Supp. 1124, 1127 (M.D. Fla. 1990) (contending
that defendant was negligent for failing to utilize process which could detect and remove
defect from blood); Kozup v. Georgetown Univ., 663 F. Supp. 1048, 1055-56 (D.D.C.
1987) (asserting that defendants negligent by failing to screen blood and implement labora-
tory tests to eliminate contaminated blood), modified, 851 F.2d 437 (D.C. Cir. 1988). It
therefore necessarily follows that negligence is the only viable cause of action for a transfu-
sion-associated AIDS plaintiff. See Comment, Hospital and Blood Bank Liability, supra note
16, at 896; Comment, Liability Without Fault, supra note 26, at 112.
- See PiossER & KEEroN, supra note 23, at 164-65.
"See Vuono v. New York Blood Center, Inc., 696 F. Supp. 743, 746-47 (D. Mass. 1988)
("negligent standard often requires that the actor's conduct could be tested against a back-
ground of ordinary usage and custom"); Comment, Hospital and Blood Bank Liability, supra
note 16, at 889-90. Conformity with industry customs and standards, however, does not
conclusively establish the absence of negligence, especially where such customs are clearly
dangerous and careless. See Vuono, 696 F. Supp. at 747; RESTATEwNT (SECOND) or ToRTS §
295 comment c (1965) ("no group of individuals and no industry or trade can be permit-
ted, by adopting careless and slipshod methods to save time, effort, or money, to set its own
uncontrolled standard at the expense of the rest of the community"). The basis for the
view that an industry standard or custom is not dispositive on the issue of negligence is the
case of The T.J. Hooper, 60 F.2d 737 (2d Cir.), cert. denied. 287 U.S. 662 (1932). In T.J.
Hooper, Judge Learned Hand opined:
There are, no doubt, cases where courts seem to make the general practice of the
calling the standard of proper diligence; we have indeed given some currency to the
notion ourselves .... Indeed in most cases reasonable prudence is in fact common
prudence; but strictly it is never its measure; a whole calling may have unduly lagged
in the adoption of new and available devices. It never may set its own tests, however
persuasive be its usages. Courts must in the end say what is required; there are pre-
cautions so imperative that even their universal disregard will not excuse their
omission.
Id. at 740.
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velop an accurate, reliable, and generally accepted method for
testing blood for such disease. ' ' 8
One obstacle facing a transfusion-related AIDS victim seeking
to recover on the theory of negligence has been the inability to
prove that a particular defendant failed to exercise reasonable
care in the testing of AIDS-contaminated blood .3  This difficulty
stems from the fact that prior to the implementation of the en-
zyme-linked immunosorbent assay ("ELISA") test in 1985, there
existed no recognized medical standard for determining whether
donated blood was infected with the Human Immunodeficiency
Virus ("HIV"), the virus which causes AIDS." Consequently, vir-
tually all pre-1985 transfusion recipients have been unable to
prove that they contracted AIDS through negligent blood test-
ing.' Moreover, despite the adoption of the ELISA test as an in-
dustry standard, recovery for a post-1985 transfusion recipient re-
mains difficult. 42 A plaintiff must prove that a defendant either
I Comment, Hospital and Blood Bank Liability, supra note 16, at 889 (citing Hutchins v.
Blood Servs., 161 Mont. 359, 362-67, 506 P.2d 449, 451-53 (1973)).
" See Comment, Hospital and Blood Bank Liability, supra note 16, at 890 (discussing negli-
gence cause of action).
40 See C. Dale, N. Jones, J. Shampansky, Blood Testing for Antibodies to the AIDS Virus: The
Legal Issues 1, in AIDS LaGAL, LEGISLATIVE, AND POUCY ISSUES 101 (N. Quist ed. 1990) (defi-
nition of HIV). Symptoms of HIV infection include:
unexplained weight loss; night sweats; blue or purple spots typical of Kaposi's sar-
coma, or on mucous membranes; swollen lymph nodes lasting more than one month;
persistent white spots or unusual blemishes in the mouth; fever greater then 99 [de-
grees] F for more than 10 days; persistent cough and shortness of breath; persistent
diarrhea.
AIDS AND THE LAW, supra note 2, app. at 346. See also Comment, Hospital and Blood Bank
Liability, supra note 16, at 879 n.23 ("[oln March 2, 1985, the ELISA test for screening
HTLV-III/LAV antibodies was licensed by the Food and Drug Administration (FDA). 50
Fed. Reg. 9909 (1985)"). For further discussion of the ELISA test, see supra notes 7-10.
"4 See Comment, Hospital and Blood Bank Liability, supra note 16, at 890. See, e.g., McKee
v. Miles Laboratories, Inc., 675 F. Supp. 1060 (E.D. Ky. 1987). In Miles, decedent's widow
brought suit against a supplier of blood coagulant, claiming that her husband's death from
AIDS was caused by the use of the defendant's product. Id. at 1061. The decedent, how-
ever, was diagnosed as having AIDS over eighteen months before the ELISA test was even
implemented. Id. Granting summary judgment to the defendant on the issue of negligence,
the court held that the lack of any test to purify or screen blood or a blood by-product for
the AIDS virus demonstrated that the blood supplier did not violate an industry standard
of care. Id. at 1064.
"a See Comment, Hospital and Blood Bank Liability, supra note 16, at 891. See generally R.
SHLTS, AND THE BAND PLAYED ON 539 (1987) (immediate distribution of ELISA test to
over 2,300 blood banks and plasma centers following test's licensing suggests establishment
of industry standard of care).
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failed to perform the ELISA test, improperly administered the
test, or failed to discard blood it knew to be contaminated .4  Such
information, however, is entirely within the purview of the de-
fendant," highlighting the necessity for plaintiffs in transfusion-
related AIDS cases to pursue discovery in order to depose the
technicians and/or health-care providers who administered the
testing procedure.
Further, despite assertions that a properly administered ELISA
test is 100 percent sensitive," the nub of the matter is that a nega-
tive test result will not preclude negligence on behalf of the de-
fendant . 6 Specifically, given that HIV antibodies may be unde-
tectable for nine to twelve months, a test performed during this
latency period may not reveal the presence of the HIV virus.' 7 It
is therefore submitted that hospitals, blood banks, or blood prod-
uct manufacturers have a duty to either re-test the blood before it
is transfused, or delay acceptance of the donated blood for a nine
to twelve month period. The need for blood suppliers to re-test or
to delay acceptance becomes more pronounced when one consid-
ers that a plaintiff will often have to respond to a defendant's af-
firmative defense that the plaintiff was infected with AIDS by
some other means than a blood transfusion." In such a case, the
mere fact that the donated blood tested HIV-negative will proba-
43 See Comment, Hospital and Blood Bank Liability, supra note 16, at 891 (discussing negli-
gence cause of action).
" Id. Unless a transfusion-related AIDS victim is able to gain access to information on
testing procedures, the plaintiff will be unable to make out a prima facie case, and a court
will then grant summary judgment to the defendant. See, e.g., Stenger v. Lehigh Valley
Hosp. Center, 386 Pa. Super. 574, 588, 563 A.2d 531, 538 (1989).
" See Comment, Transfusion-Associated AIDS, supra note 17, at 100. This commentator
noted that when the ELISA test is used in combination with the Western Blot analysis, the
effective rate of detection for the AIDS antibodies is 100 percent. Id. See also Kozup v.
Georgetown Univ., 663 F. Supp. 1048, 1053 (D.D.C. 1987), modified, 851 F.2d 437 (D.C.
Cir. 1988); Mckee v. Miles Laboratories, Inc., 675 F. Supp. 1060, 1064 (E.D. Ky. 1987).
Such a conclusion, however, is incorrect because the medical community has conclusively
determined that the current AIDS tests are not 100 percent dispositive. See Weiss, et al.,
Screening Test for HTLV-III (AIDS Agent) Antibodies, 253 J. A.M.A. 221, 223-24 (1985)
(ELISA test 98.6 percent specific and 97.3 percent sensitive for antibodies to HTLV-III/
LAV). See generally, supra notes 7-10 (discussing merits of screening tests).
" See supra notes 7-10 and accompanying text (discussing ambiguity of test results).
" See supra notes 7-10 and accompanying text (discussing ambiguity of test results).
" See, e.g., Stenger v. Lehigh Valley Hosp. Center, 386 Pa. Super. 574, 578, 563 A.2d
531, 533 (1989) (in answer to complaint, defendant denied that plaintiff contracted AIDS
from blood transfusion).
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bly serve as a bar to recovery, unless the plaintiff is permitted to
depose the donor to determine whether the blood supplier was
negligent in the screening process. 9
Moreover, liability may be established if a plaintiff is able to
prove that the defendant failed to implement, or negligently im-
plemented the prevailing screening guidelines. 50 Although the
first AIDS case was diagnosed in 198 1,51 it was not until July of
1982 that the medical community became aware of the risk of
transmission by blood transfusion, and suggested the implementa-
tion of certain preventive measures.52 In 1983, the United States
*9 See Comment, Liability Without Fault, supra note 26, at 91. Comment, Hospital and
Blood Bank Liability, supra note 16, at 891-92.
0 See, e.g., Boutte v. Blood Sys., Inc., 127 F.R.D. 122, 125 (W.D. La. 1989) (plaintiffs
claim requires proof that blood bank failed to adequately screen donor and test blood);
Kirkendall v. Harbor Ins. Co., 698 F. Supp. 768, 775 (W.D. Ark. 1988) (plaintiff must
prove liability based on failure to perform proper testing), affd 887 F.2d 857 (8th Cir.
1989); Mason v. Regional Medical Center of Hopkins County, 121 F.R.D. 300, 301 (W.D.
Ky. 1988) (discovery may lead to evidence of negligence in course of accepting, testing,
using blood); Kozup v. Georgetown Univ., 663 F. Supp. 1048, 1057 (D.D.C. 1987) (to pre-
vail on negligence theory plaintiff must prove defendant violated an established standard of
screening), modified, 851 F.2d 437 (D.C. Cir. 1988); Belle Bonfils Memorial Blood Center v.
District Court, 763 P.2d 1003, 1007 (Colo. 1988) (plaintiff must prove negligence in
screening and testing donors); Doe v. New York Univ. Medical Center, 561 N.Y.S.2d 326
(Sup.Ct. N.Y. County 1990) (plaintiff's claim requires proof that hospital failed to properly
screen or implement adequate safeguards); Tarrant County Hosp. Dist. v. Hughes, 734
S.W.2d 675, 679 (Tex. Ct. App. 1987) (donor information needed to sue for failure to
conform to standard of testing). For further discussion of blood suppliers' liability for neg-
ligent screening practices, see Williams, supra note 19, at 270-73; Comment, Hospital and
Blood Bank Liability, supra note 16, at 891-94; Comment, Liability Without Fault, supra note
26, at 85-94.
" See supra note I and accompanying text (discussing earliest known cases of AIDS).
" See Kozup v. Georgetown Univ., 663 F. Supp. 1048, 1051, 1052 (D.D.C. 1987), modi-
fied, 851 F.2d 437 (D.C. Cir. 1988). On July 27, 1982, representatives from the blood
industry, hemophiliac groups, gay community organizations, CDC, FDA, and the National
Institute of Health attended a conference in Washington, D.C., entitled an "Open Meeting
of the Public Health Service on Opportunistic Infections in Patients with Hemophilia." Id.
at 1051. At this meeting, evidence was presented that blood and blood by-products could
be a possible mode of transmission of the AIDS virus. Id. The CDC was of the opinion that
certain preventive measures should be adopted in order to curtail the potential spread of
the AIDS virus. See SmLTs, supra note 42, at 170. These measures included donor deferral
guidelines, and requested individuals who fit into the certain high-risk groups, such as
homosexuals, Haitians, and drug users, not to donate blood. Id. Despite the new evidence
of blood transmission, this conference issued no formal recommendation on donor screen-
ing. See Kozup, 663 F.Supp. at 1051.
On January 4, 1983, an ad hoc advisory committee for the United States Public Health
Services (USPHS) consisting of representatives of many of the same organizations that had
attended the July, 1982 conference on hemophilia and AIDS, met to discuss screening
guidelines. Id. at 1051. One of the primary issues raised at this meeting was the use of the
hepatitis antibodies test as a surrogate test for the AIDS virus. See SHtLTs, supra note 42, at
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Public Health Service ("USPHS") formally issued screening
guidelines for the blood industry.5 These guidelines essentially
amounted to a "voluntary self-deferral program" for potential do-
nors in the high risk category." Since the USPHS's recommenda-
tions were adopted by the blood industry as the standard of care,
in order to recover a plaintiff would have to demonstrate that the
blood supplier failed to properly implement these screening pro-
cedures, and as a consequence, plaintiff developed AIDS.5 Again,
information surrounding the circumstances of the donation can be
obtained only from the donor himself or the screening inter-
viewer." However, only the impartial donor can supply the neces-
220-21. The purpose of a surrogate test is to search "for common elements between the
disease for which the test was developed and that disease which does not yet have a test."
Comment, Liability Without Fault, supra note 26, at 87. At this conference, a CDC virologist
presented evidence that at least 80 percent of the AIDS-contaminated blood would test
positive for hepatitis core antibodies. See SHILTS, supra note 42, at 221. The CDC therefore
argued that the blood industry should implement surrogate testing since it would reduce
drastically the threat of transmitting AIDS via a transfusion. Id. at 222. The conference,
however, adjourned without issuing a recommendation for surrogate testing of donated
blood due largely to the blood industry's belief that it would be financially prohibitive to
implement this testing procedure. Id. at 223. It is interesting to note, however, that two
blood banks in California implemented surrogate testing several months after the confer-
ence ended, and by June 1, 1984, such testing was routinely done by most non-profit blood
banks through northern California. See Synder v. Mekhjian, 244 N.J. Super. 281, 289, 582
A.2d 307, 311 (N.J. Super. Ct. App. Div. 1990).
" See SmLrs, supra note 42, at 242-43.
" Id. According to these measures, members of the high-risk group were asked to re-
frain from donating blood or plasma. Id. The high-risk group, however, did not include all
homosexuals, but "merely those who were sexually active, had overt symptoms of immune
deficiency, or had engaged in sexual relations with people who did." Id. These guidelines
also did not require the screening interviewers to identify and exclude members of the
high-risk group through examinations of lymph glands and evaluating the donor's weight.
See, Comment, Liability Without Fault, supra note 26, at 88. In addition, these guidelines did
not suggest the use of surrogate testing, but rather called for studies to evaluate screening
procedures. See SsLTs. supra note 42, at 242.
" See Synder v. Mekhjian, 244 N.J. Super. 281, 293, 582 A.2d 307, 313-14 (N.J. Super.
Ct. App. Div. 1990) (allowing limited discovery to provide plaintiff access to information
regarding screening procedures); Hermann, AIDS: Malpractice and Transmission Liability, 58
U. CoLo. L. REv. 63, 81 (1986-87) (need for information regarding screening procedures).
" See Quintana v. United Blood Servs., No. 86-CV- 11750 (Denver Dist. Ct. June 3,
1988), rev'd, slip op. Colo. Ct. App. (Jan. 17, 1991) (1991 WESTLAW 3771, Allstates li-
brary); Hospital and Blood Bank Liability, supra note 16, at 891-94; Comment, Liability With-
out Fault, supra note 26, at 85-91. A transfusion-related AIDS victim could also recover
damages under the theory of negligence if he could demonstrate the industry standard of
care adopted by the blood supplier was itself negligent. See Quintana v. United Blood Sens.,
No. 86-CV-1 1750 (Denver Dist. Ct. June 3, 1988), rev'd, slip op. Colo. Ct. App. (Jan. 17,
1991) (1991 WESTLAW 3771, Allstates library) (plaintiff can present evidence which dem-
onstrates that screening and testing customs and practices in defendant's industry might
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sary information regarding the interviewer's screening process,
specifically, whether the interviewer failed to inquire if the donor
had certain diseases or symptoms, especially those opportunistic
infections which accompany AIDS." This underscores the need to
pursue discovery in order to ascertain whether proper screening
procedures were utilized. Otherwise, absent discovery, plaintiff
will be unable to establish two elements of his prima facie case: a
lack of reasonable care and causation."
not have been reasonable and prudent); Comment, Liability Without Fault, supra note 26, at
88-94. See generally The T.J. Hooper, 60 F.2d 737 (2d Cir.), cert. denied, 287 U.S. 662
(1932) (conformity with industry standard is not dispositive on issue of negligence).
One commentator has suggested that the amount of AIDS-contaminated blood in the
blood supply could have been significantly reduced had the blood industry adopted surro-
gate testing and mandatory exclusion of all persons in the high risk group, as the CDC had
suggested, rather than a policy of voluntary self deferral. See Comment, Liability Without
Fault, supra note 26, at 89; Cf. Hermann & Gorman, Hospital Liability and AIDS Treatment:
The Need for a National Standard of Care, 20 U.C. DAvts L. REv. 441, 464 (1987) (adopting
CDC guidelines for standard of care in AIDS-related litigation would provide "efficient,
clear, and authoritative basis for determining liability" since court would have definite and
manageable reference point for determining whether hospital breached its duty at particu-
lar time).
"7 See, e.g., Synder v. Mekhjian 244 N.J. Super. 281, 295, 582 A.2d 307, 315 (N.J. Super.
Ct App. Div. 1990); Belle Bonfils Memorial Blood Center v. District Court of Denver, No.
88SA45, 763 P.2d 1003, 1013 (1988) (masked donor information cards provide insufficient
information relating to defendant's screening and testing procedures). See Comment, Lia-
bility Without Fault, supra note 26, at 91-92 (donor is only impartial source of information
regarding screening procedures).
In situations where it is difficult for a plaintiff to gain knowledge of, or access to facts
surrounding the defendant's conduct, courts have permitted plaintiffs to utilize the doc-
trine of res ipsa loquitur, which creates an inference that a defendant was negligent. See
RrTATEMENT (SEcoND) or TORTS § 328D; PstossEa & KErroN, supra note 23, at 242-62.
Plaintiffs in transfusion-related AIDS cases have attempted to argue that res ipsa loquitur
should be employed to create an inference that a hospital, blood bank, or blood product
manufacturer was negligent in screening potential blood donors. See, e.g., Howell v. Spo-
kane & Inland Empire Blood Bank, 785 P.2d 815, 824 (Wash. 1990) (res ipsa loquitur not
available where plaintiff has not shown hospital had exclusive control over transfused
blood) (en banc). The doctrine of res ipsa loquitur requires that a defendant have exclusive
control over the agency or instrumentality producing the injury, which in the case of trans-
fusion-related AIDS, is the infected blood. See PuossEt & KErrON, supra note 23, at 249.
Courts have determined, however, that the exclusive control requirement cannot be met in
a transfusion case because no one defendant - whether a hospital, blood bank, or blood
product manufacturer - can be said to have exclusive control over the donated blood. See
Howell, 785 P.2d at 824. Consequently, AIDS-related plaintiffs are precluded from using
res ipsa loquitur to establish that a blood supplier was negligent in screening potential blood
donors. Id. See also Comment, Transfusion-Associated AIDS, supra note 17, at 97-98 (res ipsa
loquitur inapplicable in transfusion-related AIDS cases since AIDS virus cannot conclusively
be determined by scientifically validated test, negligence cannot be drawn solely from fact
that individual received transfusion and later contracted AIDS).
" See, e.g., Boutte v. Blood Sys., Inc., 127 F.R.D. 122, 125-26 (W.D. La. 1989) (to prose-
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11. SCOPE OF DISCOVERY
Under Federal Rule of Civil Procedure 26, "[p]arties may ob-
tain discovery regarding any matter, not privileged, which is rele-
vant to the subject matter involved in the pending action." 5' One
issue raised is whether the records of a blood bank or hospital,
which include the identity of the donor, as well as other donor
medical information, are "privileged" within a patient-physician
context, and therefore exempt from discovery under the Rule 26
exception."
A general ethical principle of medicine, which has been codified
by various state legislatures, provides that a physician has a duty
to maintain the confidentiality of communications made with a pa-
tient during the course of an examination. 1 An unauthorized dis-
cute claim plaintiff needs access to donor); Belle Bonfils Memorial Blood Center, 763 P.2d at
1013 (masked donor cards provide insufficient information to permit plaintiff to prosecute
their claim); Gulf Coast Regional Blood Center v. Houston, 745 S.W.2d 557, 560 ( Tex.
Ct. App. 1988) (unless plaintiff is able to gain knowledge of relevant facts known by donor,
plaintiff will have difficulty prosecuting claim); Tarrant County Hosp. Dist. v. Hughes, 734
S.W.2d 675, 679 ( Tex. Ct. App. 1987) (without access to donor identity it is unlikely
plaintiff can prosecute). See also Comment, Liability Without Fault, supra note 26, at 91-93.
But see Doe v. American Red Cross Blood Serv., 125 F.R.D. 646, 657 (D.S.C. 1989) ("soci-
ety's interest in maintaining an adequate and safe supply of volunteer blood, coupled with
the donor's interest in privacy, outweighs plaintiff's interest in questioning the donor");
Krygier v. Airweld, Inc., 137 Misc. 2d 306, 309, 520 N.Y.S.2d 475, 477 (Sup.Ct. Duchess
County 1987) ("Exposing donors to public scrutiny in order to determine what they may
have told [blood bank] has only marginal utility in advancing the plaintiffs theory of
liability.").
FED. R. Civ. P. 26(b) (emphasis added).
" See Doe v. American Red Cross Blood Serv., 125 F.R.D. 646, 651 (D.S.C. 1989)
(South Carolina statutes aimed at preventing Department of Health from disclosing donor
names does not render identity of donor absolutely privileged); Belle Bonfils Memorial Blood
Center, 763 P.2d at 1007 ("one issue is whether the information sought is privileged");
McDonald, Ethical Problems for Physicians Raised by AIDS and HIV Infection: Conflicting Legal
Obligations of Confidentiality and Disclosure, 22 U.C. DAvis L. REV. 557, 573 n.104 (1988)
(Federal Rules of Civil Procedure do not address issue of whether attorney of patient can
seek information regarding patient from physician) [hereinafter Ethical Problems].
11 See SMITH, STATE AND FEDERAL STATUTORY PROTECTION OF CONFIDENTIALITY IN EPIDE-
MIOLOGlC AND HEALTH CARE SErTNGs 104 (1985). See, e.g., N.Y. Civ. PRArc L. & R. § 4504
(McKinney Supp. 1990). The New York statute provides:
(a) Confidential information privileged. Unless the patient waives the privilege, a
person authorized to practice medicine, registered professional nursing or dentistry.
..shall not be allowed to disclose any information which he acquired in attending a
patient in a professional capacity, and which was necessary to enable him to act in
that capacity.
Id. See also N.Y. PuB. HEALTH LAw Art. 31 (McKinney 1990). Article 31 of the New York
State Public Health Law regulates human blood and transfusion services. The regulations
concerning blood banks are codified at 10 NYCRR 58-2 et. seq. Section 58-2.10 addresses
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closure by a physician of medical information concerning a patient
could give rise to an action in tort for invasion of privacy. 2 It
should be emphasized that this privilege operates in court-related
proceedings only.65 Furthermore, as the privilege is statutory in
nature," many states have limited the scope of the privilege,
largely curtailing its continued significance.' In addition, the
confidentiality:
the donor's name, address, telephone number, social security number and any other
information which would directly or indirectly identify the blood donor of any spe-
cific unit shall not be disclosed by the blood bank to any person or entity except
upon the written consent of the donor or except to the [New York State Depart-
ment of Health].
Id.
" See, e.g., Horne v. Patton, 291 Ala. 701, 704, 287 So. 2d 824, 825 (1973) (physician
disclosed patient information to patient's employer); Doe v. Roe, 93 Misc.2d 201, 204, 400
N.Y.S.2d 668, 671 (Sup.Ct. N.Y. County 1977) (verbatim publication by psychiatrist of
former patient's feelings, emotions, and fantasies along with diagnoses of the illness suf-
fered); Schaffer v. Spicer, 88 S.D. 36, 38, 215 N.W.2d 134, 136 (1974) (psychiatrist's affi-
davit concerning mother's mental health given to father's attorney to be used in custody
proceeding). Cf. Anderson v. Strong Memorial Hosp., 140 Misc.2d 770, 775-76, 531
N.Y.S.2d 735, 740 (Sup.Ct. Monroe County 1988) (use of photograph), a'd 151
App.Div.2d 1033, 542 N.Y.S.2d 96 (4th Dep't 1989). See generally M. GUNDERSON, D. MAYO
& F. RHAm . AIDS: TESTNG AND PRIVACY-ETHICS IN A CHANGING WORLD 75-93 (1989)
(constitutional, common law, and statutory bases of privacy actions).
" See Weiss, AIDS: Balancing the Physician's Duty to Warn and Confidentiality Concerns, 38
EMORY L.J. 279, 286-87 (1989) (historical development of confidentiality).
" J. WIGMORE, EVIDENCE IN TRiAis AT COMMON LAW § 2380 (McNaughton rev. ed.
1970). At common law no privilege between physicians and patient was recognized. See
Chase v. Schmakadeka (In re Goan), 83 Idaho 568, 575, 366 P.2d 831, 835 (1961) (physi-
cian-patient privilege is purely statutory creation, in derogation of common-law rule that
physician could be compelled to disclose information acquired in treatment of patient);
Camperlengo v. Blum, 56 N.Y.2d 251, 254, 436 N.E.2d 1299, 1300, 451 N.Y.S.2d 697,
698 (1982) (same) (citations omitted). In the absence of a statute to the contrary, no physi-
cian-patient privilege is recognized. See, e.g, Peagler v. Atlantic Coast Line R.R. Co., 101
S.E.2d 821, 825-26 (S.C. 1958) (absent statute in South Carolina, common law rule
prevails). See generally Ethical Problems, supra note 60, at 572 (whether various states recog-
nize physician-patient privilege).
" C. McCoamicx. EVmENCz § 98, 101-104 (2d ed. 1972) (some states do not recognize
privilege at all, and in states where it exists by legislative enactment, it is subject to many
exceptions and waivers for numerous reasons). Accord J. WiGMORE, § 2380, nn. 3,5, and 6.
See, e.g., Holliday v. Harrows, 91 App.Div.2d 1062, 1063, 458 N.Y.S.2d 669, 670 (2d Dep't
1983) (non-medical information not related to diagnoses or treatment is not privileged);
Williams v. Roosevelt Hosp., 66 N.Y.2d 391, 394, 488 N.E.2d 94, 97, 497 N.Y.S.2d 348,
351 (1985) ("privilege seeks to protect... confidential communications, not the mere facts
and incidents of a person's medical history"); Commonwealth ex. rel Platt v. Platt, 266 Pa.
Super. 276, 283-84, 404 A.2d 410, 414-15 (1979) (privilege not applicable to observations
as opposed to communications). A considerable number of states limit the privilege to com-
munications to the physician so far as "necessary to enable him to prescribe or act for the
patient." See, e.g., In re Zuniga, 714 F.2d 632, 640 (6th Cir.) (as general rule, privilege does
not cover patient identity), cert denied, 464 U.S. 983 (1983); CA.; EViD. CODE § 992 (Deer-
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privilege is limited in federal criminal cases and not recognized in
non-diversity cases."
Applying this principle to the case of a transfusion-related AIDS
victim attempting to prove the elements of a cause of action, it is
important to distinguish medical technicians from physicians or
professional nurses. 7 Courts addressing this issue have generally
not extended the privilege to cover revelations made by patients
to blood banks or hospitals because transfusions and blood tests in
these facilities are often performed by non-physicians, and the in-
formation is often communicated to data-storage personnel." Fur-
ther, the argument for privilege becomes increasingly tenuous
when a physician conveys patient information to hospital record
administrators or independent data systems, given the apparent
ease and likelihood of dissemination to other third parties. 9
ing 1990); N.Y. Civ. PRAc L. & R. § 4504 (McKinney Supp. 1990).
" Gellman, Prescribing Privacy: the Uncertain Role of the Physician in the Protection of Patient
Privacy, 62 N.C.L. REv. 255, 272 (1984) (regarding patient-physician privilege). See Doe v.
United States (In re Doe), 711 F.2d 1187, 1193 (2d Cir. 1983) ("since no doctor-patient
privilege existed at common law... none exists in federal law"); United States v. Meagher,
531 F.2d 752, 753 (5th Cir.) (physician-patient privilege is limited in federal criminal tri-
als), cert. denied, 429 U.S. 583 (1976). See also United States v. Kansas City Lutheran Home
and Hosp. Ass'n, 297 F. Supp. 239, 244 (W.D. Mo. 1969) (court will not recognize physi-
cian-patient privilege unless Congress so mandates).
*' See, e.g., Belle Bonfils Memorial Blood Center v. District Court, 763 P.2d 1003, 1009
(Colo. 1988) (person who interviewed donor was not a medically trained physician, sur-
geon, or professional nurse, nor were any present); Tarrant County Hosp. Dist. v. Hughes,
734 S.W.2d 675, 677 (Tex. Ct. App. 1987) ("[nlothing in the record reflects that the blood
donors were seen by a physician or received medical care when they donated blood").
' See, e.g., Doe v. American Red Cross Blood Servs., 125 F.R.D. 641, 651 n.7 (D.S.C.
1989) (holding that state statute does not prevent health history nurse from revealing the
donor's identity); Belle Bonfils Memorial Blood Center, 763 P.2d at 1009 (finding that privi-
lege does not include communications with medical technicians) (citing Block v. People,
125 Colo. 36, 240 P.2d 512 (1951), cert. denied, 343 U.S. 978 (1952)); Stenger v. Lehigh
Valley Hosp., 386 Pa.Super 574, 587, 563 A.2d 531, 537 (1989) (holding that patient-physi-
cian privilege is inapplicable where procedure was not performed by physician); Tarrant
County Hosp. Dist., 734 S.W.2d at 677 ("Nothing in the record reflects that blood donors
were seen by physician or received medical care when they donated blood"); But see United
Blood Servs. v. Nevada Dist. Court, No. 20375 (Nev. 1990) (patient-physician privilege
exists between health care provider and blood donor privilege is not absolute)
(unpublished).
" Boyer, Computerized Medical Records and the Right to Privac--Th Emerging Federal Re-
sponse, 25 BufrALO L. REv. 37, 49-51, 77 (1975). Some courts have concluded that patient
records kept by certain institutions are not protected by the physician-patient privilege,
either because of the public nature of the institutions involved or because records were
kept pursuant to a public requirement. See, e.g., Commonwealth v. Korbin, 395 Mass. 284,
292-93, 479 N.E.2d 674, 681 (1985) (information kept for Medicaid purposes not privi-
leged). Other courts have made no distinction between private and public institutions. See,
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A second issue raised is whether a blood bank or hospital can
obtain a protective order limiting the scope of discovery.70 Fed-
eral Rule of Civil Procedure 26(c) specifically provides that courts
"may make any order which justice requires to protect a party from
annoyance, embarrassment, oppression, or undue burden or expense
'971
Given the breadth of the protective provision of Rule 26(c), a
court has ample power to protect claims of privacy." Blood banks
and hospitals argue that public disclosure of the blood donor's
possible affliction with AIDS would subject that individual to such
public harassment and discrimination as to warrant a protective
order prohibiting discovery.7 8 The threat of such harassment was
a key factor motivating several courts to deny discovery of the do-
nor's identity. 4 It must be emphasized, however, that these courts
premised their decisions on the likelihood of revelation of donor
identity resulting from discovery.7 5 This assumption is inaccurate
e.g., Matter of Handicapped Child, 118 Misc.2d 137, 139, 460 N.Y.S.2d 256, 258 (Sup.Ct.
Erie County 1983) (records kept at public psychiatric facility privileged).
TO See AIDS LEGAL GUIDE 4-8 to 4-9 (A.R. Rubenfeld 2d ed. 1987). "Discovery orders do
constitute state action and therefore must respect all applicable constitutional limits, in-
cluding rights of privacy, informational privacy, and due process." Id. at 4-8.
FED. R. Civ. P. 26. (emphasis added).
See WRIGHT & MILLER, FEDERAL PRACTICE AND PROCEDURE CIVIL § 2036, at 267 (West
1970) ("Rule 26(c) was adopted as a safeguard for the protection of parties and witnesses in
view of the almost unlimited right of discovery given by Rule 26(b)"); Marrese v. American
Academy of Orthopaedic Surgeons, 726 F.2d 1150, 1159 (7th Cir. 1984) (en banc) (regard-
ing court discretion in this area), rev'd on other grounds, 470 U.S. 373 (1985). The court
stated that "a motion under Rule 26(c) to limit discovery requires the district judge to
compare hardship to the party against whom discovery is sought, if discovery is allowed,
with the hardship to the party seeking discovery, if discovery is denied." Id. See also Collins
& Aikman Corp. v.J.P. Stevens & Co., 51 F.R.D. 219, 221 (D.S.C. 1971) (need for limited
discovery in circumstances where harassment to third parties would likely result).
" See generally L. TRIBE, AMERICAN CONSTITUTIONAL LAW 1394-95 (2d ed 1988) (associa-
tion with AIDS amounts to "grievous stigma and the source of much discrimination and
harassment"). Accord Brandt, Aids: From Social History to Social Policy, 14 L. MED. & HEALTH
CARE 231, 234 (1986). See also Comment, AIDS: A Legal Epidemic?, 17 AKRON L REv. 717,
735 (1984) (man in California-who was rumored to, but did not have AIDS-was fired
from his job, received abusive phone calls, and had his house set on fire).
T' See, e.g., Coleman v. American Red Cross, 130 F.R.D. 360, 362 (E.D. Mich. 1990)
(denying discovery in light of record of discrimination against persons identified with AIDS
in jobs, housing and health care services); Doe v. American Red Cross Blood Servs., 125
F.R.D. 646, 652 (D.S.C. 1989) (citations omitted); Rasmussen v. Southern Florida Blood
Serv., 500 So.2d 533, 537 (Fla. 1987) ("[d]isclosure of donor identities in any context in-
volving AIDS could be extremely disruptive and even devastating to the individual
donor").
" See Rasmussen, 500 So.2d at 537; Coleman, 130 F.R.D. at 362; Doe, 125 F.R.D. at 652.
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for two reasons. First, it underestimates the ability of the court to
order limited anonymous discovery to contain such public revela-
tion. 6 Second, it ignores the possibility that the donor may be de-
ceased, in which case privacy issues would be of less import."
III. DONOR'S INFORMATIONAL RIGHT TO PRIVACY
The right of privacy is a relatively new development in the com-
mon law.7 8 In 1890, Samuel Warren and Louis Brandeis, noting
that "political, social, and economic changes entail the recognition
of new rights, ' 79 explored this concept and asserted that "the in-
dividual is entitled to decide whether that which is his shall be
given to the public."80 It was upon this foundation that the tort
right of invasion of privacy evolved. 1 Despite all the scholarship
on this subject, it was the effort of William Prosser who, "without
"See infra notes 149-167 and accompanying text (cases allowing discovery).
" See RESTATEMENT (SECOND) OF TORTS § 6521. Section 6521 provides: except for the
appropriation of one's name or likeness, an action for invasion of privacy can be main-
tained only by a living individual whose privacy is invaded. Id. See Lugosi v. Universal Pic-
tures, 25 Cal. 3d 813, 824, 160 Cal. Rptr. 323, 329, 603 P.2d 425, 431 (1979) (action for
invasion of privacy did not survive death and could not be asserted by anyone other than
person whose privacy has been invaded). See generally PROSSER AND KEETON. supra note 23,
§ 117, at 849.
16 See T. COOLEY, ToRTs at 91 (2d. ed. 1888) (first to recognize "right to be let alone").
While not expressly provided for in the Constitution, several state constitutions have ex-
plicitly recognized the individual's right to privacy, including Alaska, California, Florida,
Hawaii, Illinois, and Montana. See AIDS LEGAL GUIDE 4-3 (A. Rubenfeld ed. 1987). Several
other states have acknowledged a limited right to privacy, including New York, Massachu-
setts, and Pennsylvania. Id. (citing Sexual Orientations and the Law § 11.06(lXd)(viii) (R.
Achtenberg ed. 1985). See generally Note, Toward a Right of Privacy as a Matter of State
Constitutional Law, 5 FLA. ST. U.L. REV. 63.1, 690-729 (1977) (right to privacy under state
constitutions); Feigler, The Use of the State Constitutional Right to Privacy to Defeat State Sodomy
Laws, 14 N.Y.U. REV. L. & Soc. CHANGE 973, 980-83 (1986) (same).
Warren & Brandeis, The Right to Privacy, 4 HARV. L. REV. 193, 193 (1890).
Id. at 199. In considering the limitations of this right, and what remedies may be
invoked for its enforcement, the authors posited:
[t]he design of the law must be to protect those persons with whose affairs the com-
munity has no legitimate concern, from being dragged into undesirable publicity
and to protect all persons, whatsoever; their position or station, from having matters
which they may properly prefer to keep private, made public against their will.
Id. at 214-15. Cf. Bloustein, Privacy, Tort Law and the Constitution: Is Warren and Brandeis'
Tort Petty and Unconstitutional as Well?, 46 TEx. L. REV. 611 (1978) (criticism of tort of
privacy); Kalven, Jr., Privacy in Tort Law - Were Warren and Brandeis Wrong?, 31 LAW &
CONTEMPORARY PRoaLEMs 326, 328 (1966) (suggests right to privacy is petty tort).
" See Prosser, Privacy, 48 CALIF. L. REv. 383, 386 (1960). See also W. PRossER, HANDBOOK
OF THlE LAW OF TORTS § 117 (4th ed. 1971) (discusses acceptance of views of Brandeis and
Warren).
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any attempt to exact definition,"82 organized the case law into the
four categories which have come to be recognized as the current
torts of privacy.88
The United States Supreme Court initially examined the right
to privacy in the seminal case of Olmstead v. United States,'8 which
focused upon whether the fourth amendment protected against
non-trespassory government intrusions by means of a wiretap. 8"
Chief Justice Taft's majority opinion adopted a strict construction
of the amendment, and denied recognition of a privacy right
under the circumstances."' Justice Brandeis, on the other hand,
emphasized a liberal construction of the amendment, which would
"protect . .. [against] every unjustifiable intrusion by the govern-
ment upon the privacy of the individual, whatever the means
employed."87
While the Supreme Court has never fully accepted Justice Bran-
deis' dissenting opinion, 88 his expansive view of the right to pri-
vacy proved to be the cornerstone of subsequent rulings in this
" Prosser, Privacy, supra note 81, at 389.
" See RESTATEMENT (SECOND) OF TORTS § 652 A-E 1977 (adopting Prosser's categories).
The four interests and torts Prosser proffered included: (1) intrusions upon plaintiffs seclu-
sion or solitude, or into his private affairs; (2) public disclosure of embarrassing private
facts about plaintiff; (3) publicity that places the plaintiff in a false light; and (4) appropria-
tion for the defendant's advantage of the plaintiffs name or likeness. Id. For one commen-
tator's criticism of Prosser's classification scheme, see generally Bloustein, Privacy as an As-
pect of Human Dignity: An Answer to Dean Prosser, 39 N.Y.U. L. REV. 962, 1003 (1964)
("injury is to our individuality, to our dignity as individuals, and the legal remedy repre-
sents a social vindication of the human spirit thus threatened rather than a recompense for
the loss suffered").
- 277 U.S. 438 (1928).
" Id. at 456-57.
" Id. at 465. One commentator explained the decision, stating:
In effect, the majority looked upon the Fourth Amendment as a guaranty against a
particular method of invading privacy or personal security-as a ban on physical
intrusion of the house and seizure of material objects-rather than a protection of
the right of privacy itself...."
William Beany, The Constitutional Right of Privacy, 1962 SuP. CT. REV. 212, 219.
, Olmstead, 277 U.S. at 478. Justice Brandeis endeavored to extend the traditional
search and seizure concepts of the fourth amendment to intangible property such as infor-
mation. Id.
" See, e.g., United States v. Payner 447 U.S. 727 (1980) (tax returns); Dalia v. United
States, 441 U.S. 238 (1979) (warranted electronic surveillance); Whalen v. Roe, 429 U.S.
589 (1977) (prescription drug records); California Bankers Ass'n v. Schultz, 416 U.S. 21
(1974) (bank records). See generally D. O'BRIEN, PRIVACY, LAW, AND PUBLIC PoLIcY 53 (1979)
(Supreme Court never accepted Brandeis' liberal construction of fourth amendment).
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area." The Supreme Court later came to recognize a "zone of
privacy" in two areas: first, in the disclosure of personal matters,"
and second, in the independence of various types of decision-
making. 1
The breadth of the constitutional protection of an individual's
informational right to privacy in matters concerning public dis-
closure of personal information remains unclear, largely because
the Supreme Court has yet to expound on the specific expanse of
the privacy right and lower courts have differed in their treatment
of the issue.92
" See, e.g., Cruzan v. Director, Missouri Dep't of Health, 110 S. Ct. 2841 (1990) (right to
refuse medical treatment); Roe v. Wade, 410 U.S. 113 (1973) (right to abortion); Stanley v.
Georgia, 394 U.S. 557 (1969) (right to receive medical information). But see, e.g., Skinner v.
Railway Labor Executive Ass'n, 489 U.S. 602 (1989) (employee drug testing); Bowers v.
Hardwick, 478 U.S. 186 (1986) (sodomy laws). See generally Posner, The Uncertain Protection
of Privacy by the Supreme Court, 1979 SUP. CT. REV. 173, 181. The Supreme Court overruled
the Olmstead decision in 1967. See Katz v. United States, 389 U.S. 347, 353 (1967).
** See, e.g., Detroit Edison Co. v. NLRB, 440 U.S. 301, 318-19 (1978) (recognizing pri-
vacy interest as to certain employment examination results); Nixon v. Administrator of
Gen. Servs., 433 U.S. 425, 465 (1977) (regarding President's privacy right relating to cer-
tain documents); Whalen v. Roe, 429 U.S. 589, 598-600 (1977) (recognizing "individual
interest in avoiding disclosure of personal matters").
While commentators have advanced differing definitions of privacy, one theme common
to many of the definitions offered has been the individual's right of control over personal
information. See A. Mnxa. ASSAULT ON PRIvAcy 25 (1971) (privacy is "the individual's abil-
ity to control the circulation of information relating to him"); Fried, Privacy, 77 YALE L.J.
475, 482-83 (1965) ("privacy is not simply an absence of information about us in the minds
of others; rather it is the control we have over information about ourselves . . . .The
person who enjoys privacy is able to grant or deny access to others .... ); Gerety, Redefin-
ing Privacy, 12 HARV. CR.-C.L. L. REV. 233, 236 (1977) ("privacy [is] ... autonomy or
control over the intimacies of personal identity"); Gross, The Concept of Privacy, 47 N.Y.U. L.
REV. 34, 53 (1967) ("privacy is the condition of human life in which acquaintance with a
person or with affairs of his life which are personal to him is limited"); Parker, A Definition
of Privacy, 27 Rtrxas L. REV. 275, 280-81 (1974) ("privacy is control over whom and by
whom the various parts of us can be sensed by others .... It is control over the sort of
information found in dossiers and data banks").
" See, e.g., Roe v. Wade, 410 U.S. 113, 152-53 (1973) (right to privacy encompasses
woman's right to terminate pregnancy); Stanley v. Georgia, 394 U.S. 557, 568 (1969)
("zone of privacy" extends to reading and viewing materials in one's home); Griswold v.
Connecticut, 381 U.S. 479, 485-86 (1965) (marital right to privacy extends to contracep-
tive use).
" See Whalen, 429 U.S. at 602-06; Nixon, 433 U.S. at 457-58. While the Supreme Court
has previously focused on the privacy interest of disclosing information to the government,
the Court did not delineate the scope of constitutional protection relating to public dissem-
ination of information to the public. Id. See also Kimberlain v. United States Dep't of Jus-
tice, 788 F.2d 434, 438 (7th Cir. 1986) (extent of right of informational privacy has yet to
be fully defined); Barry v. City of New York, 712 F.2d 1554, 1558 (2d Cir.), cert. denied,
464 U.S. 1017 (1983).
For examples of lower court decisions discussing the individual's informational right to
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In the context of transfusion-related AIDS cases, a court must
be particularly sensitive to the donor's right to privacy-to keep
his identity and medical history confidential-because the posses-
sion of such information by unauthorized persons raises the possi-
bility of discrimination against the AIDS carrier, particularly in
the insurance and employment areas.' 8 Insurers, wary of covering
the high costs associated with medical treatment of AIDS patients,
have sought to screen for high risk groups to avoid providing cov-
erage to potential AIDS victims." Similarly, some employers have
privacy, see, J.P. v. DeSanti, 653 F.2d 1080, 1090 (6th Cir. 1981) (allowing compilation of
juvenile information); St. Michael's Convalescent Hosp. v. California, 643 F.2d 1369, 1371-
72 (9th Cir. 1981) (statute which mandated disclosure of information related to medical
program's costs did not violate informational right of privacy); United States v. Westing-
house, 638 F.2d 570, 580 (3d Cir. 1980) (government's interest in medical records out-
weighed employees' privacy interest); McElrath v. Califano, 615 F.2d 434, 441 (7th Cir.
1980) (rejecting claim disputing regulations requiring disclosure of social security number
as condition to welfare); Plante v. Gonzales, 575 F.2d 1119, 1137 (5th Cir. 1978) (using
balancing test, court held that state's interest in disclosure outweighed Senator's privacy
interest), cert. denied, 439 U.S. 1129 (1979); Williams v. Thomas Jefferson Univ., 343 F.
Supp. 1131, 1132 (E.D. Pa. 1972) (denying discovery of names of women who had abor-
tions at defendant hospital's facilities); Head v. Colloton, 331 N.W.2d 870, 876 (Iowa
1983) (denying discovery of identity of potential bone marrow donor).
" See Wash. Post Nat'l Weekly Ed., Dec. 23, 1985, at 37, col. I (quarantine of AIDS
patients). In a nation where more than one in four Americans favors putting people with
AIDS into quarantine to keep them away from the general public, the likelihood of dis-
crimination against and the consequent need to protect the privacy of AIDS carriers and
victims is apparent. Id. See also Schatz, The AIDS Insurance Crisis: Underwriting or Overreach.
ing?, 100 HARv. L. Riv. 1782, 1784 (1897) (examples of discrimination).
In 1988, the Presidential Commission on the Human Immuno-deficiency Virus, estab-
lished by the executive order of President Reagan in June 1987, issued a report detailing
the Commission's findings and recommendations on how to prevent discrimination against
HIV-infected persons. Banks, AIDS and Government: A Plan of Action?, 87 MIcH. L. REv.
1321, 1326 (1989). The report stated:
HIV-related discrimination is impairing this nation's ability to limit the spread of the
epidemic .... Public health officials will not be able to gain the confidence and
cooperation of infected individuals or those at high risk for infection if such individ-
uals fear that they will be unable to retain their jobs and their housing, and that they
will be unable to obtain the medical and support services they need because of dis-
crimination based on a positive HIV antibody test.
Id. (citing REPORT OF THE PRESIDENTIAL COMMISSION ON THE HUMAN IMMUNODEFICIENCY VI-
Rus EPIDEMIC 119 (1988)) (hereinafter "CoMISSION REPORT"].
The Commission, however, rejected the idea of proposing anti-discrimination protection
specifically tailored for HIV-carriers, but added that in "the long term, federal legislation
which clearly provides comprehensive anti-discrimination protection for all persons with
disabilities, including those with HIV-infection, is needed." Id. at 1326 n.26 (citing COM-
MISSION REPORT, at 121). The Commission also recommended that the President issue an
executive order barring discrimination against persons with AIDS by establishing HIV-in-
fection as a handicapping condition. Id. (citing COMMISSION REPORT, at 121).
" See Schatz, sup-a note 93, at 1786 (weighing public policy with financial concerns of
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fired AIDS victims in order to avoid paying higher insurance pre-
miums and to protect against the perceived threat of transmission
to other employees.' 5 Moreover, unauthorized disclosure of
AIDS-identifying information may have a devastating impact on
the victim's personal relationships since many persons," being
misinformed about methods of transmission, view AIDS as a
"modern day leprosy." '7
One issue raised is whether the donor's constitutional right to
privacy would serve to bar a transfusion recipient infected with
AIDS from discovering the donor's name and/or AIDS-identify-
ing medical records, necessary to pursue a cause of action.98 The
majority of courts which have addressed the constitutional issue of
a blood donor's informational right to privacy have allowed
discovery."
insurance industry); Note, AIDS Antibody Testing and Health Insurance Underwriting: A Para-
digmatic Inquiry, 49 OHIo ST. L.J. 1059 (1989) (insurance and discrimination). Insurers have
made efforts to avoid the cost of AIDS by testing for HIV and by identifying and rejecting
high risk applicants. Schatz, at 1805. The insurance industry has used underwriting meth-
ods to reject an unprofitable burden and shift it onto the government. Id. It is preferable
to place responsibility on the insurance industry because it is better able to evenly dis-
tribute the costs of AIDS. Id. at 1804.
e See Leonard, Employment Discrimination Against Persons with AIDS, 10 U. DAYTON L.
REV. 683, 687-89 (1985) (effect of AIDS on workplace).
" See Gray & Melton, The Law and Ethics of Psychosocial Research on AIDS, 64 NEB. L. REV.
637, 655-60 (1985). Disclosure of this information "often concerns the most intimate and
embarrassing details of a patient's life, and [its] public exposure may well strip him of much
of his own sense of human dignity." Id. at 655. Persons with AIDS are often shunned due
to fear of catching AIDS and its stigma. Id. at 656. See also Note, AIDS: A Crisis in Confiden-
tiality, 62 S. CAL. L. REV. 1701, 1708-09 (1989). Being diagnosed as having AIDS is exactly
the kind of personal information that leads to discrimination and ostracism. Id. Much of
this behavior results from the fact that AIDS is often acquired through conduct which is
not acceptable to much of our society. Id.
o See Rasmussen v. Southern Fla. Blood Servs., 500 So. 2d 533, 537 (Fla. 1987).
- See supra notes 35-58 and accompanying text (discussing need for discovery).
"See Stenger v. Lehigh Valley Hosp., 386 Pa. Super. 574, 587-88, 563 A.2d 531, 534-
35 (Pa. Super. Ct. 1989) (limited discovery from donor whose identity was protected would
not constitute an impermissible violation of donor's right to privacy); Mason v. Regional
Medical Center of Hopkins County, 121 F.R.D. 300, 303 (W.D. Ky. 1988) (no constitu-
tional protective right of privacy preventing disclosure of blood donor information, how-
ever, donor's identity would be kept confidential and revealed only to limited number of
persons); Gulf Coast Regional Blood Center v. Houston, 745 S.W.2d 557, 560-61 (Tex. Ct.
App. 1988) (plaintiffs right to discover donor's identity outweighs donor's right to pri-
vacy); Tarrant County Hosp. Dist. v. Hughes, 734 S.W.2d 675, 679 (Tex. Ct. App. 1987)
(court order compelling hospital to identify blood donors not impermissible violation of
donors' right to privacy); In Re Complex Blood Litig., No 908843, (Cal Super. Ct. San
Francisco County 1990) (limited discovery under protective order allows access to informa-
tion concerning facts and circumstances surrounding donation, but prohibiting disclosure
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To date, one case, Rasmussen v. Southern Florida Blood Ser-
vices, " has held that the right of privacy as expressed in a state
constitution encompasses the disclosure of donor identity, and
therefore denied discovery. 101 Rasmussen, however, is distinguisha-
ble from the majority of cases on point, given that Florida's con-
stitution Revision Commission specifically amended the state's
constitution with the right of informational privacy in mind.1 02
The court pointed out that "a principal aim of the constitutional
provision is to afford individuals some protection against the in-
creasing collection, retention, and use of information relating to
all facets of an individual's life.1108
Furthermore, the facts of Rasmussen are distinguishable from
other cases since the subpoena sought by petitioner would supply
unrestricted access to the names and addresses of the blood do-
nors with no limitations on potential revelation to the public.10
Consequently, the court reasoned that the potential for discrimi-
nation or harassment against the donor stemming from such un-
restricted discovery mandated the denial of plaintiff's discovery
request.1 0'
A second related issue is whether a health care provider has a
duty to disclose AIDS-related information to third par-
ties-whether or not a constitutional protection of informational
privacy exists-to initially alert the transfusion recipient of the
potential transmission of HIV from a previous transfusion. 106
of donor identity, not violative of constitutional privacy grounds); Contra Taylor v. West
Pa. Hosp., No. GD87-00206, (Pa. D & C. 3d 1987) (unpublished) (denying discovery on
constitutional privacy grounds).
:" 500 So. 2d 533 (Fla. 1987).
'*' Id. at 535-36.
Ie ld. at 535.
'I ld.; see FLA. CONST. Art. V, § 23. The Florida Constitutional amendment provides:
Right of Privacy-Every natural person has the right to be let alone and free from
governmental intrusion into his private life except as otherwise provided herein.
This section shall not be construed to limit the public's right of access to public
records and meetings as provided by law.
Id.
's Rasmussen, 500 So. 2d at 537.
I d.
'* See PosSa AND KEEroN, supra note 23, § 53, at 357. In determining whether a phy-
sician's failure to warn a third party in such circumstances is actionable, the general com-
mon law provided that "no action could be founded upon the breach of a duty owed only
to some person other than plaintiff. He must bring himself within the scope of a definite
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Since Tarasoff v. Regents of the University of California 1 7 was decided
in 1976, courts have held that in a health care context physicians
have a duty to protect third parties from potential injury through
disclosure of information regarding a patient, including a duty to
warn the identified non-patient. 08 In the area of disease transmis-
sion, it is well established that a physician may be liable in tort for
failure to warn third parties at risk that the patient has a conta-
gious disease.' 0 9 Generally, this duty is limited to informing
legal obligation . . . . 'Negligence in the air, so to speak, will not do."' Id. However, an
exception to the rule applies in cases where defendant has a protective or custodial rela-
tionship with a person whose conduct requires control. RESTATEMENT (SEcoND) OF Tonrs §
315. The Restatement provides that a duty of care may arise where:
(a) a special relation ... between the actor and the third person ... imposes a duty
upon the actor to conduct, or (b) a special relation [exists) between the actor and the
other which gives rise to the other a right of protection.
Id. See also Harper & Kime, The Duty to Control the Conduct of Another, 43 YALE L.J. 886, 887
(1934) ("there is ordinarily no duty to act for the protection of others").
107 17 Cal. 3d 425, 551 P.2d 334, 131 Cal. Rptr. 14. (1976).
I" See Tarasoff, 17 Cal.3d at 435, 131 Cal.Rptr. at 23, 551 P.2d at 335 (psychiatrist has
duty to warn potential third parties of potential dangerous patient). The Tarasoff court
balanced a number of considerations, including-
the foreseeability of harm to the plaintiff, the degree of certainty that the plaintiff
suffered injury, the closeness of the connection between the defendant's conduct and
the injury suffered, the moral blame attached to the defendant's conduct, the policy
of preventing future harm, the extent of the burden to the defendant and the conse-
quences to the community of imposing a duty to exercise care with resulting liability
for breach, and the availability, cost, and prevalence of insurance for the risk
involved.
Id. at 434, 151 P.2d at 342, 131 Cal. Rptr. at 22.
For further case law following the Tarasoff holding, see Jablonski: ex rel. Pahls v. United
States, 712 F.2d 391, 398 (9th Cir. 1983) (psychiatrists' failure to warn girlfriend that
mental patient's violence was likely to be directed at her was proximate cause of victim's
death); Lipari v. Sears, Roebuck & Co., 497 F. Supp. 185, 190 (D. Neb. 1980) (therapist
must initiate whatever precautions are reasonably necessary to protect potential victims of
patient when therapist knows or should know patient presents unreasonable risk of harm to
others); Bradley Center, Inc. v. Wessner, 296 S.E.2d 693, 696 (Ga. 1982) (private mental
health hospital liable in wrongful death action for issuing unrestricted weekend pass to
patient despite patient's previously manifested intent to kill victim); Irwin v. Town of
Ware, 392 Mass. 745, 761, 467 N.E.2d 1292, 1303-04 (1984) (town liable for negligence
when police officers failed to take into protective custody motorist who subsequently struck
and injured plaintiffs).
For various commentators' discussion of the implications of the Tarasoff decision, see
Note, The Duty to Warn Third Parties: A Retrospective on Tarasoff, 18 RtrrGms LJ. 145, 165
(1986) (Tarasoff doctrine should be refined to reflect societal and professional realities);
Note, Standard of Care, Duty, and Causation in Failure to Warn Actions against Mental Health
Professionals, 11 VT. L. Ray. 343, 344 (1986) (disagreeing with Vermont's extension of
Tarasoff doctrine); Note, Extending a Psychotherapist's Duty to Warn Beyond Protecting LifW:
Who Should Lock the Barn Door?, 1 VT. L. Ray. 353, 360 (1986) (same).
'" See, e.g., Davis v. Rodman, 227 S.W. 612, 614 (Ark. 1921) (physician has duty to
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known parties at risk. 1"
It is submitted that the Tarasoff and contagious disease cases are
analogous to the situation presented in known HIV-positive blood
transfusion cases."1 That is, as HIV is known to be transmissible
by blood contact, 12 physicians have a duty to warn recipients of
blood from donors, later identified as HIV-positive, of the poten-
tial risk"13 of developing AIDS.""
instruct family members, nurses, and medical staff of patient's typhoid fever); Skillings v.
Allen, 143 Minn. 323, 325, 173 N.W. 663, 663 (1919) (duty to warn family member of
patient's scarlet fever infection); Simonsen v. Swenson, 104 Neb. 224, 226, 177 N.W. 831,
832 (1920) (physician's warning to third party not breach of confidentiality); Wojcik v. Alu-
minum Co. of Am., 18 Misc. 2d 740, 746-47, 183 N.Y.S.2d 351, 358 (Sup. Ct. Erie County
1959) (duty to warn family).
110 Id. at 746, 183 N.Y.S.2d at 357-58.
... See Note, The Conflict Between a Doctor's Duty to Warn a Patient's Sexual Partner that the
Patient has AIDS and A Doctor's Duty to Maintain Patient Confidentiality, 45 WASH. & LEE L.
REV. 355, 374 (1988) (Tarasoff and related cases discuss doctors' dilemma in balancing pa-
tients' confidentiality and privacy rights with duty to inform others).
"I See 34 MORBIDrrY & MORTALTrrY WEEKLY REi. 561 (1985) (relating contraction of
AIDS virus to blood transfusion, sexual contact and needle injuries to hospital employees);
34 MORBIDrr & MORTALIrY WEEKLY RE'. 575 (1985) (contraction of AIDS "'in intrave-
nous drug users, blood transfusion recipients and persons with hemophilia . . .occurs via
infectious blood or blood products"); 33 MoanIDrry & MORTALTr WEEKLY REP. 181, 181-
82 (1984) (health-care workers at risk of contracting AIDS only when exposed to blood of
AIDS patients and not through casual contact, airborne spread or occupational tasks); Seli-
gan and Gosnell, AIDS: Myths and Reality, NEWSWEEK, Sept. 23, 1985, at 20-2 1. The proven
methods of transmission include sexual or blood-stream contact with an infected person;
there is, as yet, no evidence that the virus can be transmitted through casual contact, saliva,
tears, or air. Id.
"I See Ward, Letter to the Editor, 322 NEW ENG. J. OF MED. 755 (1990) (citingJ. Mosley,
et al. The Transfusion Safety Study, in Department of Health and Human Services, Abstracts
of the International Conference on AIDS 160 (1987) (not all HIV-positive blood recipients
become HIV-positive themselves)). In Ward's study, of the 38 recipients of blood from an
HIV-positive donor, 36 became infected with HIV. Id. It is not known what factors caused
these two blood recipients not to become HIV-positive. Id.
114 See Curran, Clark, & Gostin, AIDS: Legal and Policy Implications of the Application of
Traditional Disease Control Measures, 15 LAW, ME. & HATx CARE 27, 29 (1987). The
need for such notification is analogous to the justification for state law or public health
regulations providing for "contact-tracing" of sexual partners of persons diagnosed with
AIDS. Id. at 30-31. Contact-tracing is a means used by public health agencies to identify
and locate susceptible contacts of an individual known to be infected with a communicable
disease. Id. See also Gostin & Ziegler, A Review of AIDS-Related Legislative and Regulatory
Policy in the United States, 15 LAW, ME. & HEALTH CARE 5, 10 (1987) (arguments for and
against public policy options). The authors point out that as the foundation of contact-
tracing is a statutory requirement to report the disease, the program's effectiveness has
been limited as only a minority of states require HIV-positive reporting. Id; See CDC, Addi-
tional Recommendations to Reduce Sexual and Drug Abuse-Related Transmission of HTLV-III
LAV, 35 MORBIDrrY & MORTALrrY WEEKLY REP. 152 (1986). The CDC has recommended
implementing contact-tracing programs since March 1986. Id.
28
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More specifically, Congress should enact legislation mandating
the establishment of "look-back" programs by all blood-service es-
tablishments which would require physicians and/or the facilities
to effectively screen out HIV-positive blood donors and identify,
locate, and warn the transfusion recipient of the risk of infec-
tion.1 " Institution of "look-back" programs would effectively in-
terrupt the spread of the disease to the recipient's family members
and sexual partners by informing the recipient of proper health
care techniques. 116 Further, access to information assembled via a
"look-back" program would assist a donee in the discovery stage
to determine whether a viable cause of action for damages
exists.11 7
The efficacy of such a program would depend on the accuracy
of the tests used to screen for the HIV antibody. As previously
noted, the ability of the ELISA and Western Blot Tests"" to iden-
tify infected blood may not be possible during the latent stage of
disease.11' The Food and Drug Administration, therefore, should
license new tests, including the HIV antigen" and polymerase
" See AIDS AND THE LAW 235 (W. Dornette ed. 1987). The author described the "look-
back" program initiated by the American Red Cross, American Association of Blood
Banks, and the Council of Community Blood Centers in 1986. Id. One significant draw-
back of the 1986 plan is its reactive nature which depends on the initial identification of
HIV-positive transfusion recipients. Id. Such a down-stream approach will inevitably pre-
clude identification of many infected persons. Id. Sm also J.K. and Susie L Wadley Re-
search Inst. v. Morris, 776 S.W.2d 271, 279 (Tex. Ct. App. 1989) (only case where transfu-
sion recipient and his wife, who were both diagnosed as having AIDS, sued blood bank
which administered procedure, asserting liability for harm due to failure of facility to im-
plement "look-back" program).
"I See Aes UGAL GutDx 4-6 (A. Rubenfeld ed.) (1987) (citing Centers for Disease Con-
trol, Rzwmmm~wn ADDrroNAL Gumzmuu ma HIV Amrruo Coumw, 4G TIm PIazvm-
TnON oF HIV INcr-noN 4ND AIDS, app.IV (1988)).
" See supra notes 39-60 and accompanying text (problematic issues in discovery which
"look-back" programs can solve).
"I See 1988 AMmcAN BA AssOCzATION. AIDS: ma LAcu. Lssums 83 (positive ELISA tests
are confirmed by Western Blot tests).
S See supra notes 7 through 10 and accompanying text (discussing difficulty in testing
for AIDS).
I See Allain, Laurian, Paul, Seen, Serological Mareers in Early Stages of Human Immu-
nod ficiency Virus Infection in Haemophiliaca, 2 LANcrr 1233. 1233-36 (1986) (long-term
study comparing sensitivity of western blot detection and polymerase chain reaction tests);
Leslie, Reesink, Bakker, Huisman, & Ten Veen, Clinical Importance of HIV Angeiu and
Anti-HIV Core Markers in Persons Infected With HIV, 318 Naw ENo. J. Mr,. 1204 (1988)
(study concluding that HIV-antigen test is "valuable" serum marker in predicting infec-
tion); Ward et al., supra note 10, at 476 ("Assays for HIV antigens or other tests that
detect antibodies to recombinant HIV antigens may help to identify persons earlier in the
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chain reaction11" ' tests, which would likely be better overall
predictors of infection, and it should issue guidelines standard-
izing and modifying the method of performing the Western Blot
test.
2 2
IV. PUBLIC POLICY INTERESTS
In the United States, blood supplies originate from voluntary
and compensated donations. 128 There has been evidence that
blood donated by volunteers is less likely to contain impurities
than that of compensated donors."' Consequently, the federal
government encourages the expansion of the nation's voluntary
blood donation program.12 One significant argument raised by
blood banks and hospitals in opposition to plaintiffs' discovery is
that permitting revelation of donor identity will have an adverse
impact on the quantity and quality of the voluntary blood
supply."
course of HIV infection than the enzyme immuno assays currently licensed.") (citing Goud-
smit, deWolf, Paul, et al., Expression of Human Immunodeficency Virus Antigen (HIV-Ag) in
Serum and Cerebrospinal Fluid during Acute and Chronic Infection, 2 LANCET 177, 177-80
(1986)).
"I* Peterman & Ward, supra note 10, at 659-60 (recommending additional tests, includ-
ing polymerase chain reaction, to determine if donors have latent infections).
I" See D. Burke et al., Lter to the Editor, 320 NLw ENG. J. MED. 462, 462-63 (1989)
(discussing modifications in Western Blot testing procedures); R. Vogt, M.D., Letter to the
Editor, 320 NEw ENG. J. MFm. 462, 462 (1989) (there is no standardized method for per-
forming Western Blot analysis - currently at least four different "standard" criteria are
used by various laboratories) (citing Consortium for Retrovirus Standardization, Serological
Diagnosis of Human Immunodeficiency Virus Infection by Western Blot Testing, 260 J. A.M.A 674,
674-79 (1988)).
' See 21 CFR § 606.121 (cX5Xii), (iii) (1990) (volunteer donor is person who does not
receive monetary payment for blood furnished); 21 CFR § 606.121 (cX5Xi) (1990) (com-
pensated donor is one who receives monetary payment for blood provided). The Food and
Drug Administration requires that blood packaging contain specific labelling regarding do-
nor classification. 21 CFR § 606.120 (bX2) (1985).
I" See Williams, supra note 19, at 269-70 ("blood from paid donors and commercial
blood banks is more likely to be contaminated than volunteer blood"). The author, ex-
plaining the higher incidence of contaminated blood from compensated donors' supplies,
stated, "commercial blood banks tend to be located in central cities and congested urban
areas. This may lead donors who are members of groups with a high incidence of disease
like hepatitis, or who are exposed to those groups with a high incidence of disease." Id. at
270 (citing Franklin, Tort Liability for Hepatitis: An Analysis and a Proposal, 24 STAN. L. Rzv.
439, 445 (1972)).
1' See National Blood Policy, 39 Fed. Reg. 32,702 (1974) (identifying four major
problems with national blood supply system and proposing solutions).
is See Coleman v. American Red Cross, 130 F.R.D. 360, 362-63 (E.D. Mich. 1990) (us-
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Defendant blood banks and hospitals aver that the volume of
voluntarily donated blood will decrease as a consequence of dis-
covery principally because the mere hint of litigation and the pos-
sibility of public scrutiny of one's personal life will discourage vol-
unteers from donating blood."3 7 Further, they assert that the
quality of the nation's blood supply will be negatively affected be-
cause the donors will be less willing to provide the accurate, and
concomitantly personal, information on which the system relies . 2 8
It is submitted that the prediction of a negative impact on the
voluntary blood supply is purely speculative. Conceivably, allowing
anonymous limited discovery in transfusion-related AIDS cases
will have a positive impact on the nation's blood supply because
infected donors, knowing of the possibility of being involved in
future litigation, will refrain from donating blood. Furthermore,
if courts utilize anonymous limited discovery to protect the confi-
dentiality of the donor's identity, potential donors will not have to
fear public disclosure of private and often detailed medical infor-
mation, and therefore will not be discouraged from making volun-
tary donations.
Blood banks and hospitals have a significant interest in asserting
ing balancing test, court determined that possible harm to volunteer blood supply out-
weighed plaintiff's discovery needs); Doe v. American Red Cross Blood Servs., 125 F.R.D.
646, 652-53 (D.S.C. 1989) (finding donors' confidentiality of paramount importance in un-
contaminated blood supply); Mason v. Regional Medical Center of Hopkins County, 121
F.R.D. 300, 303 (W.D. Ky. 1988) (donor's identity revealed only to few because of ensuing
stigma and possible decline in overall donations); Krygier v. Airweld, Inc, 137 Misc.2d 306,
309, 520 N.Y.S.2d 475, 477 (Sup.Ct. Kings County 1987) (blood bank and "society's inter-
est in maintaining the free flow of volunteer blood far outweigh the plaintiff's right to
disclosure . . ."); Doe v. University of Cincinnati, 42 Ohio App. 3d 227, 538 N.E.2d 419
(1988) (donee denied access to donor's identity because confidentiality considered major
factor in donations). Contra Belle Bonfils Memorial Blood Center v. District Court, 763
P.2d 1003, 1012-13 (Colo. 1988) (patient's need to know donor's identity more important
than donor's right to privacy); Gulf Coast Regional Blood Center v. Houston, 745 S.W.2d
557, 559-60 (rex. Ct. App. 1988) (donee's health interests are paramount to potential ad-
verse effects on blood supply); Tarrant County Hosp. Dist. v. Hughes, 734 S.W.2d 675,
677-80 (rex. Ct. App. 1987) (donor's representatives failed to show societal interest in
blood donor program which would outweigh donee's interest in discovering donor's iden-
tity). But cf. Stenger v. Lehigh Valley Hosp. Center, 563 A.2d 531, 537 (Pa. Super. 1989)
(limited discovery allowed to protect donee because minimal risk of adversely affecting
amount of volunteer blood donations).
'F Id.
1 Id. See also American Red Cross Blood Servs., 125 F.R.D. at 652 (regarding House sub-
committee hearing on confidentiality issues related to blood donation held on July 29,
1985).
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both the donor and society's interests in preventing discovery.
That is, as previously explained, without deposing the donor it
will be virtually impossible for the plaintiff-victim to pursue his
cause of action.'"
V. BALANCING OF INTERESTS
In reaching their decisions as to the outcome of these issues,
courts apply a balancing test and weigh the interests served by al-
lowing plaintiff to proceed with discovery against the donor's
right to privacy.'" The factors to be weighed in balancing the
parties' interests were articulated by the court in United States v.
Westinghouse Electric Corp.'8 ' These include "the potential harm in
...disclosure, the injury from disclosure to the relationship in
which the record was generated, the adequacy of safeguards to
protect unauthorized disclosure, the degree of need for access,
and whether there is an express statutory mandate, articulated
public policy, or other recognizable public interest militating to-
ward access. 1 8' 2
In the area of disclosure of blood donor identity, courts have
differed in their conclusions as to the precedence of these compet-
ing interests. Several courts, in weighing the factors enumerated
above, have held that the blood donor's privacy interest and soci-
ety's dependence on a voluntary blood supply are more important
than the victim's interest in uncovering the donor's identity.183
In 1989, a South Carolina district court in Doe v. American Red
Cross Blood Services,'" held that plaintiff was not entitled to dis-
cover the identity of a transfusion donor.' Plaintiff received the
I" See supra notes 35-60 and accompanying text (discussing necessity of identifying do-
nor to bring successful claim against defendant hospital or blood bank).
I"O See Seattle Times Co. v. Rhinehart, 467 U.S. 20, 32 (1984) (court order which com-
pels or restricts pre-trial discovery constitutes state action which is subject to constitutional
limitations).
101 638 F.2d 570 (3d Cir. 1980). See also Nixon v. Administrator of Gen. Servs., 433 U.S.
425, 459 (1977) (utilization of balancing test to weigh litigants' interests).
Westinghouse Elec. Corp., 638 F.2d at 578 (3d Cir. 1980).
188 See infra notes 134-148 and accompanying text (discussing cases which have denied
discovery).
15 125 F.R.D. 646 (D.S.C. 1989).
1 American Red Cross Blood Sefs., 125 F.R.D. at 657.
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contaminated blood during a gall bladder operation.'" The court
gave priority to the donor and blood bank's interests, reasoning
that plaintiff's interest had been adequately accommodated by the
information already provided to him. 13 7
The Florida Supreme Court in Rasmussen v. Southern Florida
Blood Services'" likewise denied a blood transfusion recipient's re-
quest for discovery.18 ' In Rasmussen, plaintiff was sitting on a park
bench when he was subsequently hit by an automobile.' " During
treatment for his injuries, decedent was transfused with fifty-one
units of blood." ' He was diagnosed as having AIDS fourteen
months later. 14 The court reasoned that the "potential of signifi-
cant harm to most, if not all, of the ... donors in permitting such
a fishing expedition is great and far outweighs the plaintiffs needs
under these circumstances."""
Similarly, the New York Supreme Court in Krygier v. Airweld,
Inc.,'" held that the donor's interest in confidentiality and soci-
ety's interest in maintaining a voluntary blood supply outweighed
plaintiff's interest in obtaining discovery. " ' In Krygier, plaintiff
was critically burned by the explosion of an acetylene torch." 6
During surgery he received twenty-one units of blood, which
plaintiff alleged were contaminated with AIDS.' 7 The court em-
phasized that "[e]xposing donors to public scrutiny in order to de-
termine what they may have told [the blood bank] has only margi-
nal utility in advancing the plaintiffs theory of liability."'1 48
1M6 Id. at 647.
1Id. at 654.
18 500 So. 2d 533 (Fla. 1987).
188 Rasmussen, 500 So. 2d at 535-36.
Id. at 534.
141 Id.
149 Id.
148 Id. at 538.
14" 520 N.Y.S.2d 475 (Sup. Ct. Kings County 1987).
" Krygier, 137 Misc.2d at 309, 520 N.Y.S.2d at 477. See also Coleman v. American Red
Cross, 130 F.R.D. 360, 362 (E.D. Mich. 1990) (potential danger to voluntary blood supply
from compelled disclosure alone outweighed plaintiff's discovery needs). The Coteman
court, however, noted that "plaintiffs have failed to demonstrate either a compelling. need
for this information or any special circumstances militating in favor of disclosure of the
donor's identity." Id. at 363.
14 Krygier, 137 Misc.2d at 308, 520 N.Y.S.2d at 476.
147 Id.
I" Kygier, 137 Misc.2d at 309, 520 N.Y.S.2d at 477.
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Nonetheless, several courts have reached the opposite conclu-
sion, i.e., that the donor and society's interests are not superior to
plaintiff's right to discovery. 14'
The New Jersey Superior Court in Synder v. Mekhijian,1 50 held
that plaintiff could pursue a limited or "veiled" discovery to pro-
vide him with needed information regarding screening proce-
dures." ' In Synder, plaintiff underwent elective coronary by pass
surgery in August 1984."' In 1986, a blood-bank "look-back"
program determined that plaintiff was transfused with AIDS-in-
fected blood.153 Weighing the interests implicated, the court
granted limited discovery, stressing that "litigant's discovery need
cannot otherwise be met and it is possible to accommodate that
need with limited and controlled intrusion. ' "
In Stenger v. Lehigh Valley Hospital Center,156 the Pennsylvania
Superior Court allowed plaintiffs' request for discovery to learn of
the screening procedures used by defendant hospital.1 " In 1984,
plaintiff sustained acute personal injuries as a result of a car acci-
dent, for which she received multiple blood transfusions.11 In
1986, she, her husband, and their six month old son were diag-
nosed as being infected with AIDS. 1 " The court concluded that
"a limited and protective discovery order can be formulated ...
which will insure that the Stengers learn the information neces-
sary to establish their claim while at the same time protecting con-
fidentiality." 15' The court added that there is no correlation be-
tween discovery and a reduced number of blood donations.'"
Similarly, in Gulf Coast Regional Blood Center v. Houston,"' the
Texas Court of Appeals authorized limited discovery into the lo-
" See infra notes 150-167 and accompanying text (reviewing cases allowing discovery).
14 244 N.J. Super. 281, 582 A.2d 307 (N.J. Super Ct. App. Div. 1990).
a" Synder, 244 N.J. Super. at 297, 582 A.2d at 315.
16 Id. at 284-85, 582 A.2d at 309.
I Id.
I64 d. at 296, 582 A.2d at 314-15.
i 563 A.2d 531, 537 (Pa. Super. 1989)
14 Stenger, 563 A.2d at 539.
UI Id. at 532-33.
1I6 ld. at 533.
' Id. at 537.
I d.
'*' 745 S.W.2d 557, 559-60 (Tex. Ct. App. 1988).
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cation and identity of blood donors.1 2 In this case, plaintiff
brought a wrongful death action against a blood bank for alleged
negligence in testing and failing to warn decedent, who died of
AIDS.'" The court reasoned that the trial court effectively bal-
anced the interests of both parties by permitting a limited discov-
ery which "afforded the donors protection from undue publicity
and intrusion into their private lives."""
In Tarrant County Hospital District v. Hughes,1' the Texas Court
of Appeals also allowed discovery of donor identity,"" finding the
injury to society no less speculative than a determination that soci-
ety would benefit by discouraging donations by those infected
with AIDS."'
VI. ANONYMOUS LIMITED DISCOVERY
It is submitted that one practical approach to the problem of
balancing the respective interests of the parties would be for
courts to allow plaintiffs to pursue a anonymous limited discovery
of information from the donor. Federal Rule of Civil Procedure
26 (c) permits a court to "make any order which justice requires.
. . including . . .that the discovery be had only by a method of
discovery other than that selected by the parties seeking discov-
ery." " Given the considerable extent of discretion which a judge
possesses relating to discovery,169 the court may fashion a special
- Gulf Coast Regional Blood Center, 745 S.W.2d at 563.
'' Id. at 559.
e Id. at 560.
lo 734 S.W.2d 675, 677-80 (Tex. Ct. App. 1987).
i Tarrant County Hosp. Dist., 734 S.W.2d at 680.
Id. at 677-80.
M FED. R. Civ. P. 26(c).
There are nine principal purposes of depositions: 1) to discover evidence; 2) to dis-
cover what the witness knows or thinks; 3) to discover how a witness will testify at
trial and to commit the witness to that testimony; 4) to perpetuate helpful testimony
that may be unavailable at trial; 5) to obtain testimony to support or oppose a mo-
tion; 6) to discover an expert witness's assumptions .... opinions .... and the limits
of his studies, tests, and examinations;. 7) to assess the persuasiveness and credibility
of witnesses; 8) to establish foundation testimony needed for trial; and 9) to impress
one's opponent with the strength of one's case in order to induce a favorable
settlement.
W. Sa w azER & L. PAsAHow. Civu. Dscovaav: A GuiDE TO EmncEN"r PUAcrE 85 (1989).
1 See J. FR=Dswart, M. KANE. & A. MuLER, CIVL PaocwEuax 415 (1985) [hereinafter
Faiw mr KANE & Mun±at]. With regard to the extent of a judge's authority during the
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limited protective order allowing for an anonymous or "veiled"
discovery of donor information in transfusion-related AIDS cases,
applying discovery devices including oral depositions, 170 written
depositions, 17 1 and written interrogatories. 17  The majority of
courts to date which have employed anonymous limited discovery
discovery period, these commentators remarked:
The court also has the power to control the time, place, and atmosphere of the
discovery situation. It may make orders with respect to the way in which the discov-
ery is to be recorded, and it may be creative in its attempts to ascertain the extent to
which discovery is appropriate in a given situation. In all these ways the court may
structure or limit discovery to provide for the open exchange of information desired
by the rules, at the same time assuring that the discovery process is used only for
legitimate and non-abusive purposes.
Id.
170 See FED. R. Civ. P. 30(c). An oral deposition permits a lawyer to confront and question
any party, including a witness, regarding the subject matter of the case. Id. That person,
called the deponent, is placed under oath by an officer, usually the court reporter, who is
in charge of that deposition. See FED. R. Civ. P. 28. The function of the reporter is to
record the questions, answers, and any objections made by the parties or the witnesses. See
FED. R. Civ. P. 30(c). After the deposition has been concluded, the reporter will prepare a
transcript, which the deponent is then called upon to sign. See FED. R. Crv. P. 30(e).
An oral deposition has both advantages and disadvantages. FRIEDENTHAL KANE, &
MILLER, supra note 169, at 395. The greatest benefit of an oral deposition is that it allows
an attorney to examine a possible witness and ascertain how that witness will appear at trial
if he is called to testify. Id. On the other hand, the primary difficulty with oral depositions
is their expense. Id. at 396. Each litigant must pay not only for the effort his attorney
makes in deposing a witness but also for the cost of the deposition transcripts and probably
for witness time and travel costs. Id.
'17 See FEnDErrIHAL, KANE & MIL.E, supra note 169, at 398. A written deposition, also
known as a deposition by written questions, is like an oral deposition except that the liti-
gants' attorneys do not ask the questions. Id. Instead, both parties' attorneys will deliver
their written questions to the officer who then reads these questions to the witness whose
oral answers are then recorded. Id.; FED. K Civ. P. 31. While written depositions can be an
appropriate alternative to avoid the expense of an oral deposition, written depositions tend
to be an ineffective means to assess a deponent's strengths and weaknesses because the
lawyers do not observe the witnesses. FRlDaErNAl., KANE & Mua, supra note 169, at
399. Therefore, written depositions are most often used to acquire objective information
about matters for which no follow-up questions are likely to be required. Id.
"' See FED. R. Civ. P. 31. Written interrogatories permit one party to send another a
series of questions to be answered under oath within a specific time. Id. A court order is
not required, and the entire exchange can be accomplished by mail. Id. Unlike a deposi-
tion, however, written interrogatories may only be sent to the parties involved and not to
any person who may possess relevant information regarding the subject matter of the case.
See Fan. R Civ. P. 33(a).
One advantage of written interrogatories is that they are a relatively inexpensive means
to obtain access to a "greater range of information" since the responding party will usually
have to investigate and conduct research prior to answering. Id. The disadvantage of writ-
ten interrogatories is that since the responding party's attorney will draft the answers, they
can sometimes tend to be ambiguous. Id.
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have ordered that written,'" rather than oral,1 7" depositions be
taken, perhaps reflecting the courts' concern for the preservation
of confidentiality. 1 7
A court which employs anonymous limited discovery can amply
safeguard the donor's constitutional right to informational privacy
as the intrusion into the donor's personal affairs will be minimal.
Because the intrusion would be slight, it would not outweigh the
plaintiff-victim's right to conduct discovery which may expedite
his efforts to prove causation. Examples of some restrictions
placed on discovery include: (1) providing for deposition, at a con-
fidential date and time, to be supervised or executed by a court-
appointed referee;17 (2) allowing the donor to refrain from pro-
viding identifying information, and to disguise or conceal his
physical appearance from the reporter at deposition; 7 (3) limit-
ing the number of persons who will have access to the informa-
tion, including counsel for both parties;178 (4) prohibiting counsel
of parties from disclosing the information, either directly or indi-
rectly, to third parties without a specific court order;79 (5)
1'7 See, e.g., Boutte v. Blood Sys. Inc., 127 F.R.D. 122, 126 (W.D. La. 1989) (written
depositions ordered); Mason v. Regional Medical Center of Hopkins County, 121 F.R.D.
303, 304 (W.D. Ky. 1988) (same); In re Complex Blood Bank Litig., No. 908-843, 6-7
(1989) (same); Belle Bonfils Memorial Blood Center v. District Court, 763 P.2d 1003,
1013-14 (Colo. 1988) (same).
It must be recognized that a large number of courts have allowed for limited anonymous
discovery and provided safeguards, but did not delineate a particular method to be utilized
by plaintiff's counsel. See, e.g., Doe v. New York Univ. Medical Center. N.Y.L. J., Aug. 14,
1990, at 18, col.1-2 (Sup.Ct. N.Y.County 1990) (ordering limited discovery but failing to
delineate guidelines for carrying out order); Stenger v. Lehigh Valley Hosp., 563 A.2d
531, 539 (Pa. 1989); Gulf Coast Regional Blood Center V. Houston, 745 S.W.2d 557, 560
(Tex. Ct. App. 1988) (same); Tarrant County Hosp. Dist. v. Hughes, 734 S.W.2d 679, 680
(Tex. Ct. App. 1987) (same).
"' See United Blood Servs., No. 20375 at 2 (allowing for telephonic deposition upon locat-
ing donor).
"ll See Belle Bonfils Memorial Blood Center, 763 P.2d at 10 13 ("oral deposition pursuant to
C.R.C.P. 30 is not appropriate, as the identity of the donor must be preserved").
17, See, e.g., Boutte, 127 F.R.D. at 126; Bele Bonf!/s Memorial Blood Center, 763 P.2d at
1014; Gulf Coast Regional Blood Center, 745 S.W.2d at 560.
I"Id.
1,8 See, e.g., Belle Bonfils Memorial Blood Center, 763 P.2d at 1014 (court clerk mailed
written questions to donor and then delivered answers to attorneys after concealing any
clues to donor's name and address); Regional Medical Center of Hopkins County, 121
F.R.D. 300, 304 (W.D. Ky. 1988) (court ordered that only one attorney from each side
depose donor); Gulf Coast Regional Blood Center, 745 S.W.2d at 560 (only parties' attorneys
were allowed access to names and addresses of donors).
', But cf. Belle Bonfils Memorial Blood Center, 763 P.2d at 1014 (even court order not
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preventing the identifying information of the donor from being
revealed to any party whatsoever, including counsel; 80 (6) forbid-
ding the parties and their counsel from contacting the donor, ei-
ther directly or indirectly, or pursuing further discovery;' (7)
sealing with the court the information acquired from the do-
nor; 18 and (8) destroying the materials obtained at the close of
the case.'"
It is submitted that implementation of anonymous limited dis-
covery by a court will adequately protect the right of privacy of
the donor from the initial stages of discovery through the trial
stage. As noted above, courts may apply various techniques to
safeguard the donor's identity throughout trial proceedings.'" It
should be noted, however, that despite veiled discovery the donor
may become further involved in the litigation. Several courts have
intimated that it may be necessary to involve the donor in the
trial.1 86 In addition, defendants may assert that there is a constitu-
tional right to confront, cross-examine, and impeach an adverse
witness in a civil case, pursuant to the seventh amendment.'"
permissible to reveal donor's identity); Regional Medical Center of Hopkins County, 121
F.R.D. at 304 (court order needed to reveal donor's identity to third parties); Gulf Coast
Regional Blood Center, 745 S.W.2d at 560 (same).
iSO See United Blood Servs., v. Nevada Dist. Court, No. 20375, 7 (Nev. 1990).
See Belle Bonfils Memorial Blood Center, 763 P.2d at 1014 (court clerk was only person
allowed to have contact with donor); Gulf Coast Regional Blood Center, 745 S.W.2d at 560
(court order required to contact donor).
14 See, e.g., Belle Bonfils Memorial Blood Center, 763 P.2d at 1014 (donor's written an-
swers, name and address sealed); Gulf Coast Regional Blood Center, 745 S.W.2d at 560
(same).
I" See Gulf Coast Regional Blood Center, 745 S.W.2d at 560 (documents to be destroyed
after judgment delivered).
'" See supra notes 150-157 and accompanying text (sealing and destroying documents,
use of court clerk and denial access to donor to conceal donor identity).
I" See, e.g., Synder v. Mekhijian, 244 N.J. Super. 281, 294, 582 A.2d 307, 315 (N.J.
Super. Ct. App. Div. 1990) (donor may have no objection to openly providing
information).
'" Adickes v. S.H. Kress & Co., 398 U.S. 144, 176 (1970) (Black, J., concurring) ("right
to confront, cross examine and impeach adverse witnesses is one of the most fundamental
rights sought to be preserved by the Seventh Amendment"); Edward J. Sweeney & Sons,
Inc. v. Texaco, 637 F.2d 105, 128 (3d Cir. 1980) (deeming right to confront witnesses
fundamental especially in cases of conspiracy); Fisher v. Shamburg, 624 F.2d 156, 162
(10th Cir. 1980) (same); Singer v. Wadman, 595 F. Supp. 188, 272 (D. Utah 1982) (same);
Professional Investors Life Ins. Co. v. Roussel, 528 F. Supp. 391, 395 (D. Kan. 1981)
(same); Paton v. LaPrade, 471 F. Supp. 166, 171 (D.N.J. 1979) (same). Contra Fisher Bros.,
Inc. v. Mueller Brass Co., 630 F. Supp. 493, 497 n.7 (E.D. Pa. 1985) ("[t]here is no consti-
tutional right to confront witnesses in a civil case").
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Should it become necessary to further involve the donor in a trial,
it is suggested that a court implement procedural measures
designed to protect the donor's identity similar to the devices used
in trade secrets cases. 1a 7
CONCLUSION
Alfred North Whitehead wrote that "those who are imaginative
have but slight experience and those who are experienced have
feeble imaginations . . . ." It will take the resourcefulness and
imagination of Congress, the Executive, and the Judiciary to re-
solve the legal issues surrounding the AIDS epidemic. The utiliza-
tion by courts of anonymous limited discovery is an equitable
method of enabling victims of transfusion-related AIDS to pursue
a remedy, while at the same time, maintaining the infected do-
nor's right to privacy. This equity is especially welcome consider-
ing the possibility that unlimited discovery will adversely impact
the nation's voluntary blood supply and the fact that discovery of
a donor's identity is crucial to the plaintiff, who will likely pursue
negligence as a cause of action.
Mark G. Pedretti & Vincent L. Gallo, Jr.
,s See, e.g., In re Iowa Freedom of Information, 724 F.2d 655, 658 (8th Cir. 1983) (to
determine if there is trade secret, trade secret itself must be revealed, so do so in camera to
protect secret); Space Aero Prods. Co. v. R.E. Darling Co., 238 Md. 93, 122, 208 A.2d 74,
89 (Md. 1968) (secrecy is primary protection, so exclude all witnesses except expert wit-
nesses); Air Prods. and Chems., Inc. v. Johnson, 442 A.2d 1114, 1128 (Pa. Super. Ct.
1982) ("public disclosure of a trade secret, by a party seeking to protect its interests results
in an abandonment of that trade secret"). It has long been recognized that where litigation
involves trade secrets a trial court has the discretionary authority to implement various
procedural safeguards designed to prevent public disclosure of confidential information in
the course of trial. Id. See also Note, Publicker Industries v. Cohen: Public Access to Civil Pro-
eedings and a Corporation's Right to Privacy, 80 Nw. U.L. Rxv. 1319, 1342-50 (1987) (balanc-
ing risks, constitutionality, and effectiveness of closing trade secret trials to public obser-
vance); Comment, The First Amendment Right of Access to Civil Trials After Globe Newspaper
Co. v. Superior CL, 51 U. CHI. L. Rav. 286, 302-06 (1984) (recent cases in which trade secrets
were not legitimate and cldsed trial was not needed).
For a discussion of the various techniques which could be utilized by a court in attempt-
ing to shield an AIDS-infected donor's identity, see F.T.C. v. Lonning, 539 F.2d 202 (D.C.
Cir. 1976) (limiting disclosure of information to counsel of record); United States v. Inter-
national Business Machs. Corp., 67 F.R.D. 40, 43 (S.D.N.Y. 1975) (in camera proceedings);
Sun Dial Corp. v. Rideout, 29 N.J. Super. 361, 102 A.2d 90 (N.J. Super. Ct.) (deleting
details from record), affld, 16 N.J. 252, 108 A.2d 442 (1954).
I" AN. WHrrEHEAD, SCIENCE AND THE MODERN WoaLD 24 (1925).

